8000,0,"Neoplasm, benign",preferred
8000,0,"Tumor, benign",alternate
8000,0,"Unclassified tumor, benign",alternate
8000,1,"Neoplasm, uncertain whether benign or malignant",preferred
8000,1,"Neoplasm, NOS",alternate
8000,1,"Tumor, NOS",alternate
8000,1,"Unclassified tumor, uncertain whether benign or malignant",alternate
8000,1,"Unclassified tumor, borderline malignancy",alternate
8000,2,"Neoplasm, in situ",preferred
8000,3,"Neoplasm, malignant",preferred
8000,3,"Blastoma, NOS",alternate
8000,3,"Tumor, malignant, NOS",alternate
8000,3,Malignancy,alternate
8000,3,Cancer,alternate
8000,3,"Unclassified tumor, malignant",alternate
8000,6,"Neoplasm, metastatic",preferred
8000,9,"Neoplasm, malignant, uncertain whether primary or metastatic",preferred
8001,0,"Tumor cells, benign",preferred
8001,1,"Tumor cells, uncertain whether benign or malignant",preferred
8001,1,"Tumor cells, NOS",alternate
8001,3,"Tumor cells, malignant",preferred
8002,3,"Malignant tumor, small cell type",preferred
8003,3,"Malignant tumor, giant cell type",preferred
8004,3,"Malignant tumor, spindle cell type",preferred
8004,3,"Malignant tumor, fusiform cell type",alternate
8005,0,"Clear cell tumor, NOS",preferred
8005,3,"Malignant tumor, clear cell type",preferred
8010,0,"Epithelial tumor, benign",preferred
8010,2,"Carcinoma in situ, NOS",preferred
8010,2,"Intraepithelial carcinoma, NOS",alternate
8010,3,"Carcinoma, NOS",preferred
8010,3,"Epithelial tumor, malignant",alternate
8010,3,"Urachal carcinoma (C65.9, C66.9, C67._, C68._)",alternate
8010,6,"Carcinoma, NOS",preferred
8010,9,Carcinomatosis,preferred
8011,0,"Epithelioma, benign",preferred
8011,2,"Epithelioma, in situ",preferred
8011,3,"Epithelioma, malignant",preferred
8011,3,"Epithelioma, NOS",alternate
8012,2,"Large cell carcinoma, in situ",preferred
8012,3,"Large cell carcinoma, NOS",preferred
8013,3,Large cell neuroendocrine carcinoma,preferred
8013,3,"Combined large cell neuroendocrine carcinoma (C34._, C37.9)",alternate
8014,3,Large cell carcinoma with rhabdoid phenotype,preferred
8015,3,Glassy cell carcinoma,preferred
8020,3,"Carcinoma, undifferentiated, NOS",preferred
8021,3,"Carcinoma, anaplastic, NOS",preferred
8022,2,Pleomorphic carcinoma in situ,preferred
8022,3,Pleomorphic carcinoma,preferred
8023,3,"NUT carcinoma (C30.0, C31.9, C34._)",preferred
8023,3,"Midline carcinoma of children and young adults with NUT rearrangement (C30.0, C31.9, C34._)",alternate
8023,3,"NUT midline carcinoma (C30.0, C31.9, C34._)",alternate
8030,2,Giant cell and spindle cell carcinoma in situ,preferred
8030,3,Giant cell and spindle cell carcinoma,preferred
8031,2,Giant cell carcinoma in situ,preferred
8031,3,Giant cell carcinoma,preferred
8032,2,Spindle cell carcinoma in situ,preferred
8032,3,"Spindle cell carcinoma, NOS",preferred
8033,2,"Pseudosarcomatous carcinoma, in situ",preferred
8033,3,Pseudosarcomatous carcinoma,preferred
8033,3,Sarcomatoid carcinoma,alternate
8034,3,Polygonal cell carcinoma,preferred
8035,3,Carcinoma with osteoclast-like giant cells,preferred
8040,0,"Tumorlet, benign",preferred
8040,1,"Tumorlet, NOS",preferred
8040,3,"Tumorlet, malignant",preferred
8041,2,"Small cell carcinoma, in situ",preferred
8041,3,"Small cell carcinoma, NOS",preferred
8041,3,Small cell carcinoma pulmonary type (C56.9),alternate
8041,3,Reserve cell carcinoma,alternate
8041,3,Round cell carcinoma,alternate
8041,3,Small cell neuroendocrine carcinoma,alternate
8041,3,"High-grade neuroendocrine carcinoma (C54._, C55.9)",alternate
8041,3,"Neuroendocrine carcinoma, poorly differentiated (C50._)",alternate
8042,2,Oat cell carcinoma in situ (C34._),preferred
8042,3,Oat cell carcinoma (C34._),preferred
8043,3,"Small cell carcinoma, fusiform cell (C34._)",preferred
8044,3,"Small cell carcinoma, intermediate cell (C34._)",preferred
8044,3,"Small cell carcinoma, hypercalcemic type (C56.9)",alternate
8045,3,Combined small cell carcinoma (C34._),preferred
8045,3,Mixed small cell carcinoma,alternate
8045,3,Combined small cell-large cell carcinoma,alternate
8045,3,Combined small cell-adenocarcinoma,alternate
8045,3,Combined small cell-squamous cell carcinoma,alternate
8046,2,Non-small cell carcinoma in situ (C34._),preferred
8046,3,Non-small cell carcinoma (C34._),preferred
8050,0,"Papilloma, NOS",preferred
8050,1,Papilloma of uncertain malignant potential,preferred
8050,2,Papillary carcinoma in situ,preferred
8050,3,"Papillary carcinoma, NOS",preferred
8051,0,Verrucous papilloma,preferred
8051,2,Verrucous carcinoma in situ,preferred
8051,3,"Verrucous carcinoma, NOS",preferred
8051,3,Verrucous epidermoid carcinoma,alternate
8051,3,Warty carcinoma (pre-2018),alternate
8051,3,Condylomatous carcinoma (pre-2018),alternate
8051,3,Verrucous squamous cell carcinoma,alternate
8052,0,"Squamous cell papilloma, NOS",preferred
8052,0,Squamous papilloma,alternate
8052,0,Keratotic papilloma,alternate
8052,2,"Papillary squamous cell carcinoma, non-invasive",preferred
8052,2,Papillary squamous cell carcinoma in situ,alternate
8052,3,Papillary squamous cell carcinoma,preferred
8052,3,Papillary epidermoid carcinoma,alternate
8053,0,"Squamous cell papilloma, inverted",preferred
8053,3,"Squamous cell papilloma, inverted, malignant",preferred
8054,3,"Warty carcinoma (C60.0-C60.2, C60.9)",preferred
8054,3,"Condylomatous carcinoma (C60.0-C60.2, C60.9)",alternate
8060,0,Squamous papillomatosis,preferred
8060,0,"Papillomatosis, NOS",alternate
8070,2,"Squamous cell carcinoma in situ, NOS",preferred
8070,2,"Epidermoid carcinoma in situ, NOS",alternate
8070,2,"Intraepidermal carcinoma, NOS",alternate
8070,2,Intraepithelial squamous cell carcinoma,alternate
8070,3,"Squamous cell carcinoma, NOS",preferred
8070,3,"Epidermoid carcinoma, NOS",alternate
8070,3,Squamous carcinoma,alternate
8070,3,Squamous cell epithelioma,alternate
8070,6,"Squamous cell carcinoma, metastatic, NOS",preferred
8071,2,"Squamous cell carcinoma in situ, keratinizing, NOS",preferred
8071,2,Differentiated penile intraepithelial neoplasia (C60._),alternate
8071,2,Differentiated-type vulvar intraepithelial neoplasia (C51._),alternate
8071,3,"Squamous cell carcinoma, keratinizing, NOS",preferred
8071,3,"Squamous cell carcinoma, large cell, keratinizing",alternate
8071,3,"Epidermoid carcinoma, keratinizing",alternate
8072,2,"Squamous cell carcinoma, large cell, nonkeratinizing, in situ",preferred
8072,3,"Squamous cell carcinoma, large cell, nonkeratinizing, NOS",preferred
8072,3,"Epidermoid carcinoma, large cell, nonkeratinizing",alternate
8072,3,"Squamous cell carcinoma, nonkeratinizing, NOS",alternate
8073,2,"Squamous cell carcinoma, small cell, nonkeratinizing, in situ",preferred
8073,3,"Squamous cell carcinoma, small cell, nonkeratinizing",preferred
8073,3,"Epidermoid carcinoma, small cell, nonkeratinizing",alternate
8074,2,"Squamous cell carcinoma, spindle cell, in situ",preferred
8074,3,"Squamous cell carcinoma, spindle cell",preferred
8074,3,"Epidermoid carcinoma, spindle cell",alternate
8074,3,"Squamous cell carcinoma, sarcomatoid",alternate
8075,2,"Squamous cell carcinoma, adenoid, in situ",preferred
8075,3,"Squamous cell carcinoma, adenoid",preferred
8075,3,"Squamous cell carcinoma, pseudoglandular",alternate
8075,3,"Squamous cell carcinoma, acantholytic",alternate
8076,2,Squamous cell CIS with questionable stromal invasion (C53._),preferred
8076,2,Epidermoid carcinoma in situ with questionable stromal invasion,alternate
8076,3,"Squamous cell carcinoma, micro-invasive (C53._)",preferred
8077,2,"Squamous intraepithelial neoplasia, grade III",preferred
8077,2,Penile intraepithelial neoplasia grade 3,alternate
8077,2,PeIN III,alternate
8077,2,Laryngeal intraepithelial neoplasia grade 3,alternate
8077,2,Conjunctival intraepithelial neoplasia grade 3,alternate
8077,2,"Cervical intraepithelial neoplasia, grade III",alternate
8077,2,"CIN III, NOS",alternate
8077,2,CIN III with severe dysplasia,alternate
8077,2,"Vaginal intraepithelial neoplasia, grade III",alternate
8077,2,VAIN III,alternate
8077,2,"Vulvar intraepithelial neoplasia, grade III",alternate
8077,2,VIN III,alternate
8077,2,"Anal intraepithelial neoplasia, grade III",alternate
8077,2,AIN III,alternate
8077,3,"Squamous cell carcinoma, grade III (C53._)",preferred
8078,3,Squamous cell carcinoma with horn formation,preferred
8080,2,Queyrat erythroplasia (C60._),preferred
8080,3,"Queyrat erythroplasia, malignant (C60._)",preferred
8081,2,Bowen disease (C44._),preferred
8081,2,"Intraepidermal squamous cell carcinoma, Bowen type",alternate
8081,3,"Bowen's disease, malignant (C44._)",preferred
8082,2,Lymphoepithelial carcinoma in situ,preferred
8082,3,Lymphoepithelial carcinoma,preferred
8082,3,Lymphoepithelioma,alternate
8082,3,Lymphoepithelioma-like carcinoma,alternate
8082,3,Schmincke tumor,alternate
8083,2,Basaloid squamous cell carcinoma in situ,preferred
8083,3,Basaloid squamous cell carcinoma,preferred
8084,3,"Squamous cell carcinoma, clear cell type",preferred
8085,3,"Squamous cell carcinoma, HPV-positive (C01.9, C09.9, C10.2, C10.3, C10.8, C10.9, C31.0-C31.3, C31.9)",preferred
8086,3,"Squamous cell carcinoma, HPV-negative (C01.9, C09.9, C10.2, C10.3, C10.8, C10.9, C31.0-C31.3, C31.9)",preferred
8090,1,Basal cell tumor (C44._),preferred
8090,2,Basal cell carcinoma in situ (C44._),preferred
8090,3,"Basal cell carcinoma, NOS (C44._)",preferred
8090,3,Basal cell epithelioma,alternate
8090,3,Rodent ulcer,alternate
8090,3,Pigmented basal cell carcinoma,alternate
8091,2,"Multicentric basal cell carcinoma, in situ (C44._)",preferred
8091,3,Multifocal superficial basal cell carcinoma (C44._),preferred
8091,3,Multicentric basal cell carcinoma,alternate
8092,3,"Infiltrating basal cell carcinoma, NOS (C44._)",preferred
8092,3,"Infiltrating basal cell carcinoma, non-sclerosing",alternate
8092,3,"Infiltrating basal cell carcinoma, sclerosing",alternate
8092,3,"Basal cell carcinoma, morpheic",alternate
8092,3,"Basal cell carcinoma, desmoplastic type",alternate
8093,3,"Basal cell carcinoma, fibroepithelial (C44._)",preferred
8093,3,Fibroepithelioma of Pinkus type,alternate
8093,3,"Fibroepithelial basal cell carcinoma, Pinkus type",alternate
8093,3,Pinkus tumor,alternate
8093,3,"Fibroepithelioma, NOS",alternate
8094,2,Basosquamous carcinoma in situ (C44._),preferred
8094,3,Basosquamous carcinoma (C44._),preferred
8094,3,Mixed basal-squamous cell carcinoma,alternate
8095,3,Metatypical carcinoma (C44._),preferred
8096,0,Intraepidermal epithelioma of Jadassohn (C44._),preferred
8097,3,"Basal cell carcinoma, nodular (C44._)",preferred
8097,3,"Basal cell carcinoma, micronodular",alternate
8098,3,Adenoid basal cell carcinoma (C53._),preferred
8100,0,Trichoepithelioma (C44._),preferred
8100,0,Brooke tumor,alternate
8100,0,Epithelioma adenoides cysticum,alternate
8100,3,"Trichoepithelioma, malignant (C44._)",preferred
8101,0,Trichofolliculoma (C44._),preferred
8102,0,Trichilemmoma (C44._),preferred
8102,3,Trichilemmocarcinoma (C44._),preferred
8102,3,Trichilemmal carcinoma,alternate
8103,0,Pilar tumor (C44._),preferred
8103,0,Proliferating trichilemmal cyst,alternate
8103,0,Proliferating trichilemmal tumor,alternate
8103,3,"Pilar tumor, malignant (C44._)",preferred
8110,0,Pilomatrixoma (C44._),preferred
8110,0,Calcifying epithelioma of Malherbe,alternate
8110,0,"Pilomatricoma, NOS",alternate
8110,3,Pilomatrix carcinoma (C44._),preferred
8110,3,"Pilomatrixoma, malignant",alternate
8110,3,"Pilomatricoma, malignant",alternate
8110,3,Matrical carcinoma,alternate
8120,0,"Transitional cell papilloma, benign",preferred
8120,0,Transitional papilloma,alternate
8120,1,"Urothelial papilloma, NOS (C65.9, C66.9, C67._)",preferred
8120,1,Papilloma of bladder,alternate
8120,1,"Transitional cell papilloma, NOS",alternate
8120,2,"Transitional cell carcinoma in situ (C65.9, C66.9, C67._)",preferred
8120,2,Urothelial carcinoma in situ,alternate
8120,3,"Transitional cell carcinoma, NOS (C65.9, C66.9, C67._)",preferred
8120,3,"Urothelial carcinoma, NOS",alternate
8120,3,Transitional carcinoma,alternate
8120,3,"Lipid-rich urothelial carcinoma (C65.9, C66.9, C67._, C68._)",alternate
8120,3,"Microcystic urothelial carcinoma (C65.9, C66.9, C67._, C68._)",alternate
8120,3,"Nested urothelial carcinoma (C65.9, C66.9, C67._, C68._)",alternate
8120,3,Squamotransitional cell carcinoma (C53._),alternate
8120,3,"Urothelial carcinoma with divergent differentiation (C65.9, C66.9, C67._, C68._)",alternate
8120,3,"Urothelial carcinoma with squamous differentiation (C65.9, C66.9, C67._, C68._)",alternate
8120,3,"Urothelial carcinoma with trophoblastic differentiation (C65.9, C66.9, C67._, C68._)",alternate
8120,3,"Clear cell (glycogen-rich) urothelial carcinoma (C65.9, C66.9, C67._, C68._)",alternate
8121,0,"Schneiderian papilloma, NOS (C30.0, C31._)",preferred
8121,0,"Sinonasal papilloma, NOS",alternate
8121,0,"Sinonasal papilloma, exophytic",alternate
8121,0,"Sinonasal papilloma, fungiform",alternate
8121,0,"Transitional cell papilloma, inverted, benign",alternate
8121,0,"Transitional papilloma, inverted, benign",alternate
8121,1,"Transitional cell papilloma, inverted, NOS (C30.0, C31._)",preferred
8121,1,"Transitional papilloma, inverted, NOS",alternate
8121,1,"Schneiderian papilloma, inverted",alternate
8121,1,Columnar cell papilloma,alternate
8121,1,Cylindrical cell papilloma,alternate
8121,1,Oncocytic Schneiderian papilloma,alternate
8121,2,"Transitional cell carcinoma in situ, inverted, NOS (C30.0, C31._)",preferred
8121,3,"Schneiderian carcinoma (C30.0, C31._)",preferred
8121,3,Cylindrical cell carcinoma,alternate
8122,3,"Transitional cell carcinoma, spindle cell",preferred
8122,3,"Transitional cell carcinoma, sarcomatoid",alternate
8123,2,"Basaloid carcinoma, in situ (C21.1)",preferred
8123,3,Basaloid carcinoma (C21.1),preferred
8124,2,Cloacogenic carcinoma in situ (C21.2),preferred
8124,3,Cloacogenic carcinoma (C21.2),preferred
8130,1,Papillary transitional cell neoplasm of low malignant potential,preferred
8130,1,Papillary urothelial neoplasm of low malignant potential,alternate
8130,2,"Papillary transitional cell carcinoma, non-invasive (C65.9, C66.9, C67._)",preferred
8130,2,"Papillary urothelial carcinoma, non-invasive",alternate
8130,3,Papillary transitional cell carcinoma,preferred
8130,3,Papillary urothelial carcinoma,alternate
8131,2,"Transitional cell carcinoma in situ, micropapillary",preferred
8131,3,"Transitional cell carcinoma, micropapillary",preferred
8140,0,"Adenoma, NOS (C61.9)",preferred
8140,1,Atypical adenoma (C34._),preferred
8140,1,"Bronchial adenoma, NOS",alternate
8140,2,"Adenocarcinoma in situ, NOS",preferred
8140,3,"Adenocarcinoma, NOS",preferred
8140,3,"Minimally invasive adenocarcinoma, NOS (C34._)",alternate
8140,3,Endocervical adenocarcinoma usual type (C53._),alternate
8140,3,Acinar adenocarcinoma (C61.9 ONLY),alternate
8140,6,"Adenocarcinoma, metastatic, NOS",preferred
8141,2,Scirrhous adenocarcinoma in situ,preferred
8141,3,Scirrhous adenocarcinoma,preferred
8141,3,Scirrhous carcinoma,alternate
8141,3,Carcinoma with productive fibrosis,alternate
8142,3,Linitis plastica (C16._),preferred
8143,2,Superficial spreading adenocarcinoma in situ,preferred
8143,3,Superficial spreading adenocarcinoma,preferred
8144,2,"Adenocarcinoma in situ, intestinal type (C16._)",preferred
8144,3,"Adenocarcinoma, intestinal type (C16._)",preferred
8144,3,"Enteric adenocarcinoma (C34. 0, C65.9, C66.9, C67._, C68._)",alternate
8144,3,"Intestinal-type adenocarcinoma (C30.0, C53._)",alternate
8144,3,"Mucinous carcinoma, intestinal type (C53._)",alternate
8144,3,"Carcinoma, intestinal type",alternate
8145,2,"Carcinoma in situ, diffuse type (C16._)",preferred
8145,3,"Carcinoma, diffuse type (C16._)",preferred
8145,3,"Adenocarcinoma, diffuse type",alternate
8146,0,Monomorphic adenoma,preferred
8146,2,"Monomorphic adenoma, in situ",preferred
8146,3,Monomorphic adenocarcinoma,preferred
8147,0,"Basal cell adenoma (C07._, C08._)",preferred
8147,3,"Basal cell adenocarcinoma (C07._, C08._)",preferred
8148,2,"Glandular intraepithelial neoplasia, grade III",preferred
8148,2,"Prostatic intraepithelial neoplasia, grade III",alternate
8148,2,PIN III,alternate
8148,2,High grade biliary intraepithelial neoplasia,alternate
8148,2,Biliary intraepithelial neoplasia grade 3,alternate
8148,2,BilIN III,alternate
8148,2,PanIN III,alternate
8148,2,Pancreatic intraepithelial neoplasia grade 3,alternate
8149,0,Canalicular adenoma,preferred
8150,0,"Pancreatic endocrine tumor, benign (C25._) (ICD-O-3 update)",preferred
8150,0,Islet cell adenoma (C25._),alternate
8150,0,Pancreatic microadenoma (C25._),alternate
8150,0,"Islet cell tumor, benign",alternate
8150,0,Nesidioblastoma,alternate
8150,0,Islet cell adenomatosis,alternate
8150,1,"Pancreatic endocrine tumor, NOS (C25._) (ICD-O-3 update)",preferred
8150,1,"Islet cell tumor, NOS (C25._)",alternate
8150,3,"Pancreatic endocrine tumor, malignant (C25._) (ICD-O-3 update)",preferred
8150,3,Islet cell carcinoma (C25._),alternate
8150,3,"Pancreatic endocrine tumor, nonfunctioning (C25._)",alternate
8150,3,Islet cell adenocarcinoma,alternate
8151,0,"Insulinoma, NOS (C25._)",preferred
8151,0,Beta cell adenoma,alternate
8151,3,"Insulinoma, malignant (C25._)",preferred
8151,3,"Beta cell tumor, malignant",alternate
8152,1,"Glucagonoma, NOS (C25._)",preferred
8152,1,L-cell tumor,alternate
8152,1,Glucagon-like peptide-producing tumor (C25._),alternate
8152,1,Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor,alternate
8152,1,"Alpha cell tumor, NOS",alternate
8152,1,PP/PYY producing tumor,alternate
8152,3,"Glucagonoma, malignant (C25._)",preferred
8152,3,"Alpha cell tumor, malignant",alternate
8153,0,"Gastrinoma, benign (C25._)",preferred
8153,1,"Gastrinoma, NOS (C25._)",preferred
8153,1,"G cell tumor, NOS",alternate
8153,1,Gastrin cell tumor,alternate
8153,3,"Gastrinoma, malignant (C25._)",preferred
8153,3,"G cell tumor, malignant",alternate
8153,3,"Gastrin cell tumor, malignant",alternate
8154,3,"Mixed pancreatic endocrine and exocrine tumor, malignant (C25._) (ICD-O-3 updated)",preferred
8154,3,Mixed islet cell and exocrine adenocarcinoma (C25._),alternate
8154,3,Mixed acinar-endocrine-ductal carcinoma,alternate
8154,3,Mixed acinar-endocrine carcinoma,alternate
8154,3,Mixed ductal-endocrine carcinoma,alternate
8154,3,Mixed endocrine and exocrine adenocarcinoma (C25._),alternate
8155,1,"Vipoma, NOS",preferred
8155,3,"Vipoma, malignant",preferred
8156,1,"Somatostatinoma, NOS (C25._)",preferred
8156,1,"Somatostatin cell tumor, NOS",alternate
8156,3,"Somatostatinoma, malignant (C25._)",preferred
8156,3,"Somatostatin cell tumor, malignant",alternate
8157,1,"Enteroglucagonoma, NOS (C25._)",preferred
8157,3,"Enteroglucagonoma, malignant (C25._)",preferred
8158,1,"Endocrine tumor, functioning, NOS",preferred
8158,1,ACTH-producing tumor,alternate
8160,0,"Bile duct adenoma (C22.1, C24.0)",preferred
8160,0,Cholangioma,alternate
8160,2,"Bile duct adenocarcinoma in situ (C22.1, C24.0)",preferred
8160,3,"Cholangiocarcinoma (C22.1, C24.0)",preferred
8160,3,Bile duct carcinoma,alternate
8160,3,Bile duct adenocarcinoma,alternate
8161,0,Bile duct cystadenoma (C22.0),preferred
8161,3,Bile duct cystadenocarcinoma (C22.1),preferred
8162,3,Klatskin tumor (C22.1),preferred
8163,3,Pancreatobiliary-type carcinoma (C24.1),preferred
8163,3,"Adenocarcinoma, pancreatobiliary-type (C24.1)",alternate
8170,0,Liver cell adenoma (C22.0),preferred
8170,0,Hepatocellular adenoma,alternate
8170,0,"Hepatoma, benign",alternate
8170,2,Hepatocellular carcinoma in situ (C22.0),preferred
8170,3,"Hepatocellular carcinoma, NOS (C22.0)",preferred
8170,3,"Hepatoma, NOS",alternate
8170,3,Liver cell carcinoma,alternate
8170,3,Hepatocarcinoma,alternate
8170,3,"Hepatoma, malignant",alternate
8171,3,"Hepatocellular carcinoma, fibrolamellar (C22.0)",preferred
8172,3,"Hepatocellular carcinoma, scirrhous (C22.0)",preferred
8172,3,Sclerosing hepatic carcinoma,alternate
8173,3,"Hepatocellular carcinoma, spindle cell variant (C22.0)",preferred
8173,3,"Hepatocellular carcinoma, sarcomatoid",alternate
8174,3,"Hepatocellular carcinoma, clear cell type (C22.0)",preferred
8175,3,"Hepatocellular carcinoma, pleomorphic type (C22.0)",preferred
8180,3,Combined hepatocellular carcinoma and cholangiocarcinoma (C22.0),preferred
8180,3,Mixed hepatocellular and bile duct carcinoma,alternate
8180,3,Hepatocholangiocarcinoma,alternate
8190,0,Trabecular adenoma,preferred
8190,3,Trabecular adenocarcinoma,preferred
8190,3,Trabecular carcinoma,alternate
8191,0,Embryonal adenoma,preferred
8200,0,Eccrine dermal cylindroma (C44._),preferred
8200,0,Turban tumor,alternate
8200,0,Cylindroma of skin,alternate
8200,2,Adenoid cystic carcinoma in situ,preferred
8200,3,Adenoid cystic carcinoma,preferred
8200,3,Thymic carcinoma with adenoid cystic carcinoma-like features (C37.9),alternate
8200,3,Adenocystic carcinoma,alternate
8200,3,"Cylindroma, NOS",alternate
8200,3,"Adenocarcinoma, cylindroid",alternate
8200,3,"Bronchial adenoma, cylindroid",alternate
8201,2,Cribriform carcinoma in situ (C50._),preferred
8201,2,"Ductal carcinoma in situ, cribriform type",alternate
8201,3,"Cribriform carcinoma, NOS (C50._)",preferred
8201,3,"Cribriform comedo-type carcinoma (C18._, C19.9, C20.9)",alternate
8201,3,"Adenocarcinoma, cribriform comedo-type (C18._, C19.9, C20.9)",alternate
8201,3,"Ductal carcinoma, cribriform type",alternate
8202,0,Microcystic adenoma (C25._),preferred
8204,0,Lactating adenoma (C50._),preferred
8210,0,"Adenomatous polyp, NOS",preferred
8210,0,Polypoid adenoma,alternate
8210,2,Adenocarcinoma in situ in adenomatous polyp,preferred
8210,2,Carcinoma in situ in adenomatous polyp,alternate
8210,2,Adenocarcinoma in situ in polypoid adenoma,alternate
8210,2,"Adenocarcinoma in situ in a polyp, NOS",alternate
8210,2,"Carcinoma in situ in a polyp, NOS",alternate
8210,2,Adenocarcinoma in situ in tubular adenoma,alternate
8210,3,Adenocarcinoma in adenomatous polyp,preferred
8210,3,Adenocarcinoma in tubular adenoma,alternate
8210,3,Carcinoma in adenomatous polyp,alternate
8210,3,Adenocarcinoma in polypoid adenoma,alternate
8210,3,"Adenocarcinoma in a polyp, NOS",alternate
8210,3,"Carcinoma in a polyp, NOS",alternate
8211,0,"Tubular adenoma, NOS",preferred
8211,2,Tubular adenocarcinoma in situ,preferred
8211,3,Tubular adenocarcinoma,preferred
8211,3,Tubular carcinoma,alternate
8212,0,Flat adenoma,preferred
8213,0,Serrated adenoma,preferred
8213,0,Traditional serrated adenoma,alternate
8213,0,Sessile serrated adenoma,alternate
8213,0,Sessile serrated polyp,alternate
8213,0,Traditional sessile serrated adenoma,alternate
8213,0,Mixed adenomatous and hyperplastic polyp,alternate
8213,2,"Serrated adenoma, in situ",preferred
8213,3,"Serrated adenocarcinoma (C18.0, C18.2, C18.9, C19.9, C20.9)",preferred
8214,3,Parietal cell carcinoma,preferred
8214,3,Parietal cell adenocarcinoma,alternate
8215,3,Adenocarcinoma of anal glands (C21.1),preferred
8215,3,Adenocarcinoma of anal ducts,alternate
8220,0,Adenomatous polyposis coli (C18._),preferred
8220,0,Familial polyposis coli,alternate
8220,0,"Adenomatosis, NOS",alternate
8220,2,Adenocarcinoma in situ in adenomatous polyposis coli (C18._),preferred
8220,3,Adenocarcinoma in adenomatous polyposis coli (C18._),preferred
8221,0,Multiple adenomatous polyps,preferred
8221,2,Adenocarcinoma in situ in multiple adenomatous polyposis coli,preferred
8221,3,Adenocarcinoma in multiple adenomatous polyposis coli,preferred
8230,2,"Ductal carcinoma in situ, solid type",preferred
8230,2,"Intraductal carcinoma, solid type",alternate
8230,3,"Solid carcinoma, NOS",preferred
8230,3,Solid carcinoma with mucin formation,alternate
8230,3,Solid adenocarcinoma with mucin formation,alternate
8231,3,Carcinoma simplex,preferred
8240,0,"Carcinoid tumor, benign",preferred
8240,1,Carcinoid tumor of uncertain malignant potential (C18.1),preferred
8240,1,"Carcinoid tumor, NOS, of appendix",alternate
8240,1,"Carcinoid, NOS, of appendix",alternate
8240,1,"Carcinoid tumor, argentaffin, NOS",alternate
8240,1,"Argentaffinoma, NOS",alternate
8240,2,"Carcinoid tumor, in situ (C18.1)",preferred
8240,3,"Carcinoid tumor, NOS",preferred
8240,3,"Carcinoid, NOS",alternate
8240,3,Typical carcinoid,alternate
8240,3,"Bronchial adenoma, carcinoid",alternate
8240,3,"Neuroendocrine tumor, grade 1",alternate
8240,3,"Neuroendocrine carcinoma, low grade",alternate
8240,3,"Neuroendocrine carcinoma, well-differentiated",alternate
8240,6,"Carcinoid tumor, NOS",preferred
8241,0,"Enterochromaffin cell carcinoid, benign",preferred
8241,3,Enterochromaffin cell carcinoid,preferred
8241,3,"Carcinoid tumor, argentaffin, malignant",alternate
8241,3,"Argentaffinoma, malignant",alternate
8241,3,EC cell carcinoid,alternate
8241,3,Serotonin producing carcinoid,alternate
8241,6,Enterochromaffin cell carcinoid,preferred
8242,0,"Enterochromaffin-like cell carcinoid, benign",preferred
8242,1,"Enterochromaffin-like cell carcinoid, NOS",preferred
8242,1,"ECL cell carcinoid, NOS",alternate
8242,3,"Enterochromaffin-like cell tumor, malignant",preferred
8242,3,"ECL cell carcinoid, malignant",alternate
8242,6,"Enterochromaffin-like cell tumor, malignant",preferred
8243,3,Goblet cell carcinoid,preferred
8243,3,Mucinous carcinoid,alternate
8243,3,Mucocarcinoid tumor,alternate
8243,6,Goblet cell carcinoid,preferred
8244,2,"Mixed adenoneuroendocrine carcinoma, in situ (ICD-O-3 update)",preferred
8244,3,Mixed adenoneuroendocrine carcinoma,preferred
8244,3,Combined carcinoid and adenocarcinoma,alternate
8244,3,Mixed carcinoid-adenocarcinoma,alternate
8244,3,Composite carcinoid,alternate
8244,3,Combined/mixed carcinoid and adenocarcinoma,alternate
8244,3,MANEC,alternate
8245,1,Tubular carcinoid,preferred
8245,3,Adenocarcinoid tumor,preferred
8245,6,Adenocarcinoid tumor,preferred
8246,2,Neuroendocrine carcinoma in situ,preferred
8246,3,"Neuroendocrine carcinoma, NOS",preferred
8246,3,"Neuroendocrine tumor, well differentiated (C50._)",alternate
8246,6,"Neuroendocrine carcinoma, NOS",preferred
8247,2,"Merkel cell carcinoma, in situ (C44._)",preferred
8247,3,Merkel cell carcinoma (C44._),preferred
8247,3,Merkel cell tumor,alternate
8247,3,Primary cutaneous neuroendocrine carcinoma,alternate
8247,6,Merkel cell carcinoma (C44._),preferred
8248,1,Apudoma,preferred
8248,3,"Apudoma, malignant",preferred
8249,3,Atypical carcinoid tumor,preferred
8249,3,"Neuroendocrine tumor, grade 2",alternate
8249,3,"Neuroendocrine carcinoma, moderately differentiated",alternate
8249,6,Atypical carcinoid tumor,preferred
8250,1,Pulmonary adenomatosis (C34._),preferred
8250,2,"Adenocarcinoma in situ, non-mucinous (C34._)",preferred
8250,2,Bronchio-alveolar adenocarcinoma in situ (C34._),alternate
8250,3,Lepidic adenocarcinoma (C34._),preferred
8250,3,"Bronchiolo-alveolar carcinoma, NOS",alternate
8250,3,Bronchiolar adenocarcinoma,alternate
8250,3,Bronchiolar carcinoma,alternate
8250,3,Lepidic predominant adenocarcinoma (C34._),alternate
8250,3,Alveolar cell carcinoma,alternate
8250,3,"Bronchio-alveolar adenocarcinoma, NOS (C34._)",alternate
8251,0,Alveolar adenoma (C34._),preferred
8251,3,Alveolar adenocarcinoma (C34._),preferred
8251,3,Alveolar carcinoma,alternate
8252,2,"Bronchio-alveolar carcinoma, non-mucinous in situ (C34._)",preferred
8252,3,"Bronchio-alveolar carcinoma, non-mucinous (C34._)",preferred
8252,3,"Bronchiolo-alveolar carcinoma, Clara cell",alternate
8252,3,"Bronchiolo-alveolar carcinoma, type II pneumocyte",alternate
8253,2,"Bronchio-alveolar carcinoma, mucinous, in situ (C34._)",preferred
8253,2,"Adenocarcinoma in situ, mucinous (C34._)",alternate
8253,3,Invasive mucinous adenocarcinoma (C34._),preferred
8253,3,"Bronchio-alveolar carcinoma, mucinous (C34._)",alternate
8253,3,"Bronchiolo-alveolar carcinoma, goblet cell type",alternate
8254,3,Mixed invasive mucinous and non-mucinous adenocarcinoma (C34._),preferred
8254,3,"Bronchio-alveolar carcinoma, mixed mucinous and non-mucinous (C34._)",alternate
8254,3,"Bronchiolo-alveolar carcinoma, Clara cell and goblet cell type",alternate
8254,3,"Bronchiolo-alveolar carcinoma, type II pneumocyte and goblet cell type",alternate
8254,3,"Bronchiolo-alveolar carcinoma, indeterminate type",alternate
8255,2,"Adenocarcinoma with mixed subtypes, in situ",preferred
8255,3,Adenocarcinoma with mixed subtypes,preferred
8255,3,Adenocarcinoma combined with other types of carcinoma,alternate
8256,3,"Minimally invasive adenocarcinoma, non-mucinous (C34._)",preferred
8257,3,"Minimally invasive adenocarcinoma, mucinous (C34._)",preferred
8260,0,"Papillary adenoma, NOS",preferred
8260,0,Glandular papilloma,alternate
8260,2,"Papillary adenocarcinoma in situ, NOS",preferred
8260,3,"Papillary adenocarcinoma, NOS",preferred
8260,3,Papillary carcinoma of thyroid,alternate
8260,3,Papillary renal cell carcinoma,alternate
8261,0,"Villous adenoma, NOS",preferred
8261,0,Villous papilloma,alternate
8261,2,Adenocarcinoma in situ in villous adenoma,preferred
8261,3,Adenocarcinoma in villous adenoma,preferred
8262,2,Villous adenocarcinoma in situ,preferred
8262,3,Villous adenocarcinoma,preferred
8263,0,"Tubulovillous adenoma, NOS",preferred
8263,0,Tubulo-papillary adenoma,alternate
8263,0,Villoglandular adenoma,alternate
8263,0,Papillotubular adenoma,alternate
8263,2,Adenocarcinoma in situ in tubulovillous adenoma,preferred
8263,3,Adenocarcinoma in tubulovillous adenoma,preferred
8263,3,Papillotubular adenocarcinoma,alternate
8263,3,Tubulopapillary adenocarcinoma,alternate
8263,3,"Endometrioid adenocarcinoma, villoglandular (C54._, C55.9)",alternate
8263,3,Villoglandular carcinoma (C53._),alternate
8264,0,"Papillomatosis, glandular (C22.1, C24.0)",preferred
8264,0,Biliary papillomatosis,alternate
8265,3,"Micropapillary carcinoma, NOS (C18._, C19.9, C20.9, C34._)",preferred
8265,3,Micropapillary adenocarcinoma (C34._),alternate
8270,0,Chromophobe adenoma (C75.1),preferred
8270,1,"Chromophobe adenoma, borderline (C75.1)",preferred
8270,3,Chromophobe carcinoma (C75.1),preferred
8270,3,Chromophobe adenocarcinoma,alternate
8271,0,Prolactinoma (C75.1),preferred
8271,3,"Prolactinoma, malignant (C75.1)",preferred
8272,0,"Pituitary adenoma, NOS (C75.1)",preferred
8272,1,"Pituitary, borderline malignancy (C75.1)",preferred
8272,3,"Pituitary carcinoma, NOS (C75.1)",preferred
8280,0,Acidophil adenoma (C75.1),preferred
8280,0,Eosinophil adenoma,alternate
8280,3,Acidophil carcinoma (C75.1),preferred
8280,3,Acidophil adenocarcinoma,alternate
8280,3,Eosinophil carcinoma,alternate
8280,3,Eosinophil adenocarcinoma,alternate
8281,0,Mixed acidophil-basophil adenoma (C75.1),preferred
8281,3,Mixed acidophil-basophil carcinoma (C75.1),preferred
8290,0,Oxyphillic adenoma (C73.9),preferred
8290,0,Oncocytoma,alternate
8290,0,Hurthle cell adenoma,alternate
8290,0,Spindle cell oncocytoma (C75.1),alternate
8290,0,Hurthle cell tumor,alternate
8290,0,"Follicular adenoma, oxyphilic cell",alternate
8290,0,Oncocytic adenoma,alternate
8290,2,Oxyphillic adenocarcinoma in situ (C73.9),preferred
8290,3,Oxyphillic adenocarcinoma (C73.9),preferred
8290,3,Oncocytic carcinoma,alternate
8290,3,Oncocytic adenocarcinoma,alternate
8290,3,Hurthle cell carcinoma,alternate
8290,3,Hurthle cell adenocarcinoma,alternate
8290,3,"Follicular carcinoma, oxyphilic cell",alternate
8300,0,Basophil adenoma (C75.1),preferred
8300,0,Mucoid cell adenoma,alternate
8300,3,Basophil carcinoma (C75.1),preferred
8300,3,Basophil adenocarcinoma,alternate
8300,3,Mucoid cell adenocarcinoma,alternate
8310,0,Clear cell adenoma,preferred
8310,2,Clear cell adenocarcinoma in situ,preferred
8310,3,"Clear cell adenocarcinoma, NOS",preferred
8310,3,Clear cell carcinoma,alternate
8310,3,"Clear cell adenocarcinoma, mesonephroid",alternate
8311,1,Hypernephroid tumor [obs],preferred
8311,3,Hereditary leiomyomatosis & RCC- associated renal cell carcinoma (C64.9),preferred
8311,3,MiT family translocation renal cell carcinoma (C64.9),alternate
8312,2,Renal cell carcinoma in situ (C64.9),preferred
8312,3,Renal cell carcinoma (C64.9),preferred
8312,3,Hypernephroma,alternate
8312,3,"Renal cell carcinoma, unclassified (C64.9)",alternate
8312,3,Renal cell adenocarcinoma,alternate
8312,3,Grawitz tumor,alternate
8313,0,Clear cell adenofibroma (C56.9),preferred
8313,0,Clear cell cystadenofibroma,alternate
8313,1,Clear cell adenofibroma of borderline malignancy (C56.9),preferred
8313,1,Clear cell cystadenofibroma of borderline malignancy,alternate
8313,3,Clear cell adenocarcinofibroma (C56.9),preferred
8313,3,Clear cell cystadenocarcinofibroma,alternate
8314,3,Lipid-rich carcinoma (C50._),preferred
8315,3,Glycogen-rich carcinoma (C50._),preferred
8316,2,Cyst-associated renal cell carcinoma in situ (C64.9),preferred
8316,3,Cyst-associated renal cell carcinoma (C64.9),preferred
8316,3,Acquired cystic disease-associated renal cell carcinoma (RCC) (C64.9),alternate
8316,3,Tubulocystic renal cell carcinoma (C64.9),alternate
8317,3,"Renal cell carcinoma, chromophobe type (C64.9)",preferred
8317,3,Chromophobe cell renal carcinoma,alternate
8318,3,"Renal cell carcinoma, sarcomatoid (C64.9)",preferred
8318,3,"Renal cell carcinoma, spindle cell",alternate
8319,3,Collecting duct carcinoma (C64.9),preferred
8319,3,Bellini duct carcinoma,alternate
8319,3,"Renal carcinoma, collecting duct type",alternate
8320,3,Granular cell carcinoma,preferred
8320,3,Granular cell adenocarcinoma,alternate
8321,0,Chief cell adenoma (C75.0),preferred
8322,0,Water-clear cell adenoma (C75.0),preferred
8322,3,Water-clear cell adenocarcinoma (C75.0),preferred
8322,3,Water-clear cell carcinoma,alternate
8323,0,Mixed cell adenoma,preferred
8323,2,Mixed cell adenocarcinoma in situ,preferred
8323,3,Mixed cell adenocarcinoma,preferred
8324,0,Lipoadenoma,preferred
8324,0,Adenolipoma,alternate
8325,0,Metanephric adenoma (C64._),preferred
8325,3,Metanephric adenocarcinoma (C64._),preferred
8330,0,Follicular adenoma (C73.9),preferred
8330,1,Atypical follicular adenoma (C73.9),preferred
8330,2,Follicular adenocarcinoma in situ (C73.9),preferred
8330,3,"Follicular adenocarcinoma, NOS (C73.9)",preferred
8330,3,"Follicular carcinoma, NOS",alternate
8331,3,Follicular adenocarcinoma well differentiated (C73.9),preferred
8331,3,"Follicular carcinoma, well differentiated",alternate
8332,3,Follicular adenocarcinoma trabecular (C73.9),preferred
8332,3,"Follicular carcinoma, trabecular",alternate
8332,3,"Follicular adenocarcinoma, moderately differentiated",alternate
8332,3,"Follicular carcinoma, moderately differentiated",alternate
8333,0,"Microfollicular adenoma, NOS (C73.9)",preferred
8333,0,Fetal adenoma,alternate
8333,3,Fetal adenocarcinoma,preferred
8334,0,Macrofollicular adenoma (C73.9),preferred
8334,0,Colloid adenoma,alternate
8335,2,Macrofollicular carcinoma in situ (C73.9),preferred
8335,3,"Follicular carcinoma, minimally invasive (C73.9)",preferred
8335,3,"Follicular carcinoma, encapsulated",alternate
8336,0,Hyalinizing trabecular adenoma (C73.9),preferred
8337,3,Insular carcinoma (C73.9),preferred
8339,3,"Follicular thyroid carcinoma (FTC), encapsulated angoinvasive (C73.9)",preferred
8340,2,"Papillary carcinoma follicular variant, in situ follicular variant (C73.9)",preferred
8340,3,"Papillary carcinoma, follicular variant (C73.9)",preferred
8340,3,"Papillary adenocarcinoma, follicular variant",alternate
8340,3,Papillary and follicular adenocarcinoma,alternate
8340,3,Papillary and follicular carcinoma,alternate
8341,2,Papillary microcarcinoma in situ (C73.9),preferred
8341,3,Papillary microcarcinoma (C73.9),preferred
8342,2,"Papillary carcinoma, encapsulated, in situ (C73.9)",preferred
8342,3,"Papillary carcinoma, oxyphilic cell (C73.9)",preferred
8343,2,Non-invasive EFVPTC (C73.9),preferred
8343,2,Non-invasive encapsulated follicular variant of papillary thyroid carcinoma (non-invasive EFVPTC) (C73.9),alternate
8343,2,Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) (C73.9),alternate
8343,2,Non-invasive FTP (C73.9),alternate
8343,3,"Papillary carcinoma, encapsulated (C73.9)",preferred
8343,3,"Encapsulated follicular variant of papillary thyroid carcinoma, NOS (EFVPTC, NOS) (C73.9)",alternate
8343,3,Invasive encapsulated follicular variant of papillary thyroid carcinoma (invasive EFVPTC) (C73.9),alternate
8344,3,"Papillary carcinoma, columnar cell (C73.9)",preferred
8344,3,"Papillary carcinoma, tall cell",alternate
8345,3,Medullary carcinoma with amyloid stroma (C73.9),preferred
8345,3,Parafollicular cell carcinoma,alternate
8345,3,C cell carcinoma,alternate
8346,3,Mixed medullary-follicular carcinoma (C73.9),preferred
8347,3,Mixed medullary-papillary carcinoma (C73.9),preferred
8350,3,Nonencapsulated sclerosing carcinoma (C73.9),preferred
8350,3,Nonencapsulated sclerosing adenocarcinoma,alternate
8350,3,Nonencapsulated sclerosing tumor,alternate
8350,3,"Papillary carcinoma, diffuse sclerosing",alternate
8360,1,Multiple endocrine adenomas (C75.8),preferred
8360,1,Endocrine adenomatosis,alternate
8361,0,Juxtaglomerular tumor (C64._),preferred
8361,0,Reninoma,alternate
8370,0,"Adrenal cortical adenoma, NOS (C74.0)",preferred
8370,0,"Adrenal cortical tumor, benign",alternate
8370,0,"Adrenal cortical tumor, NOS",alternate
8370,2,Adrenal cortical carcinoma in situ (C74.0),preferred
8370,3,Adrenal cortical carcinoma (C74.0),preferred
8370,3,Adrenal cortical adenocarcinoma,alternate
8370,3,"Adrenal cortical tumor, malignant",alternate
8371,0,"Adrenal cortical adenoma, compact cell (C74.0)",preferred
8372,0,"Adrenal cortical adenoma, pigmented (C74.0)",preferred
8372,0,Black adenoma,alternate
8372,0,Pigmented adenoma,alternate
8373,0,"Adrenal cortical adenoma, clear cell (C74.0)",preferred
8374,0,"Adrenal cortical adenoma, glomerulosa cell (C74.0)",preferred
8375,0,"Adrenal cortical adenoma, mixed cell (C74.0)",preferred
8380,0,"Endometrioid adenoma, NOS (C56.9 [F], C61.9 [M])",preferred
8380,0,"Endometrioid cystadenoma, NOS",alternate
8380,1,"Endometrioid adenoma, borderline malignancy (C56.9 [F], C61.9 [M])",preferred
8380,1,"Endometrioid cystadenoma, borderline malignancy",alternate
8380,1,Endometrioid tumor of low malignant potential,alternate
8380,1,Atypical proliferative endometrioid tumor,alternate
8380,2,"Endometrioid adenocarcinoma in situ (C56.9 [F], C61.9 [M])",preferred
8380,2,Atypical hyperplasia/Endometrioid intraepithelial neoplasm (C54._),alternate
8380,3,Endometrioid carcinoma (C56.9),preferred
8380,3,"Endometrioid carcinoma, NOS",alternate
8380,3,Endometrioid cystadenocarcinoma,alternate
8381,0,"Endometrioid adenofibroma, NOS (C56.9 [F], C61.9 [M])",preferred
8381,0,"Endometrioid cystadenofibroma, NOS",alternate
8381,1,"Endometrioid adenofibroma, borderline malignancy (C56.9 [F], C61.9 [M])",preferred
8381,1,"Endometrioid cystadenofibroma, borderline malignancy",alternate
8381,2,"Endometrioid adenofibroma in situ (C56.9 [F], C61.9 [M])",preferred
8381,3,"Endometrioid adenofibroma, malignant (C56.9 [F], C61.9 [M])",preferred
8381,3,"Endometrioid cystadenofibroma, malignant",alternate
8382,2,"Endometrioid adenocarcinoma in situ, secretory variant (C56.9 [F], C61.9 [M])",preferred
8382,3,"Endometrioid adenocarcinoma, secretory variant (C56.9 [F], C61.9 [M])",preferred
8383,3,"Endometrioid adenocarcinoma, ciliated cell variant (C56.9 [F], C61.9 [M])",preferred
8384,2,"Adenocarcinoma, endocervical type, in situ (C53._)",preferred
8384,3,"Adenocarcinoma, endocervical type (C53._)",preferred
8390,0,Skin appendage adenoma (C44._),preferred
8390,0,"Skin appendage tumor, benign",alternate
8390,0,"Adnexal tumor, benign",alternate
8390,2,Skin appendage carcinoma in situ (C44._),preferred
8390,3,Skin appendage carcinoma (C44._),preferred
8390,3,Adnexal carcinoma,alternate
8391,0,Follicular fibroma (C44._),preferred
8391,0,Trichodiscoma,alternate
8391,0,Fibrofolliculoma,alternate
8391,0,Perifollicular fibroma,alternate
8392,0,Syringofibroadenoma (C44._),preferred
8400,0,Sweat gland adenoma (C44._),preferred
8400,0,"Sweat gland tumor, benign",alternate
8400,0,"Hidradenoma, NOS",alternate
8400,0,"Syringadenoma, NOS",alternate
8400,1,"Sweat gland tumor, NOS (C44._)",preferred
8400,2,Sweat gland adenocarcinoma in situ (C44._),preferred
8400,3,Sweat gland adenocarcinoma (C44._),preferred
8400,3,Sweat gland carcinoma,alternate
8400,3,"Sweat gland tumor, malignant",alternate
8401,0,Apocrine adenoma (C44._),preferred
8401,0,Apocrine cystadenoma,alternate
8401,2,Apocrine adenocarcinoma in situ (C44._),preferred
8401,3,Apocrine adenocarcinoma (C44._),preferred
8402,0,Nodular hidradenoma (C44._),preferred
8402,0,Eccrine acrospiroma,alternate
8402,0,Clear cell hidradenoma,alternate
8402,2,"Nodular hidradenoma, in situ (C44._)",preferred
8402,3,"Nodular hidradenoma, malignant (C44._)",preferred
8402,3,Hidradenocarcinoma,alternate
8403,0,Eccrine spiradenoma (C44._),preferred
8403,0,"Spiradenoma, NOS",alternate
8403,3,Malignant eccrine spiradenoma (C44._),preferred
8404,0,Hidrocystoma (C44._),preferred
8404,0,Eccrine cystadenoma,alternate
8405,0,Papillary hidradenoma (C44._),preferred
8405,0,Hidradenoma papilliferum,alternate
8406,0,Papillary syringadenoma (C44._),preferred
8406,0,Syringocystadenoma papilliferum,alternate
8406,0,Papillary syringocystadenoma,alternate
8406,3,Papillary syringadenocarcinoma (C44._),preferred
8407,0,"Syringoma, NOS (C44._)",preferred
8407,3,Sclerosing sweat duct carcinoma (C44._),preferred
8407,3,Syringomatous carcinoma,alternate
8407,3,Microcystic adnexal carcinoma,alternate
8408,0,Eccrine papillary adenoma (C44._),preferred
8408,1,Aggressive digital papillary adenoma (C44._),preferred
8408,3,Eccrine papillary adenocarcinoma (C44._),preferred
8408,3,Digital papillary adenocarcinoma,alternate
8409,0,Eccrine poroma (C44._),preferred
8409,2,"Eccrine poroma, in situ (C44._)",preferred
8409,3,"Eccrine poroma, malignant (C44._)",preferred
8409,3,Porocarcinoma,alternate
8410,0,Sebaceous adenoma (C44._),preferred
8410,0,Sebaceous epithelioma,alternate
8410,2,Sebaceous adenocarcinoma in situ (C44._),preferred
8410,3,Sebaceous adenocarcinoma (C44._),preferred
8410,3,Sebaceous carcinoma,alternate
8413,3,Eccrine adenocarcinoma (C44._),preferred
8420,0,Ceruminous adenoma (C44.2),preferred
8420,3,Ceruminous adenocarcinoma (C44.2),preferred
8420,3,Ceruminous carcinoma,alternate
8430,1,Mucoepidermoid tumor [OBS],preferred
8430,2,Mucoepidermoid carcinoma in situ,preferred
8430,3,Mucoepidermoid carcinoma,preferred
8440,0,"Cystadenoma, NOS",preferred
8440,0,"Cystoma, NOS",alternate
8440,2,"Cystadenocarcinoma, in situ",preferred
8440,3,"Cystadenocarcinoma, NOS",preferred
8441,0,"Serous cystadenoma, NOS (C56.9)",preferred
8441,0,Serous cystoma,alternate
8441,0,Serous microcystic adenoma,alternate
8441,2,"Serous cystadenoma in situ, NOS (C56.9)",preferred
8441,2,"Serous endometrial intraepithelial carcinoma (C54._, C55.9)",alternate
8441,2,Serous tubal intraepithelial carcinoma (C57.0),alternate
8441,3,"Serous cystadenocarcinoma, NOS (C56.9)",preferred
8441,3,"Serous adenocarcinoma, NOS",alternate
8441,3,"Serous carcinoma, NOS",alternate
8442,1,"Serous cystadenoma, borderline malignancy (C56.9)",preferred
8442,1,"Serous tumor, NOS, of low malignant potential",alternate
8442,1,Atypical proliferating serous tumor,alternate
8442,2,Proliferating serous carcinoma in situ (C56.9),preferred
8442,3,Proliferating serous carcinoma malignant (C56.9),preferred
8443,0,Clear cell cystadenoma (C56.9),preferred
8443,3,Clear cell cystadenocarcinoma (C56.9),preferred
8444,1,Clear cell cystic tumor of borderline malignancy (C56.9),preferred
8444,1,Atypical proliferating clear cell tumor,alternate
8444,3,"Clear cell cystic tumor, malignant (C56.9)",preferred
8450,0,"Papillary cystadenoma, NOS (C56.9)",preferred
8450,2,"Papillary cystadenocarcinoma in situ, NOS (C56.9)",preferred
8450,3,"Papillary cystadenocarcinoma, NOS (C56.9)",preferred
8450,3,Papillocystic adenocarcinoma,alternate
8451,1,"Papillary cystadenoma, borderline malignancy (C56.9)",preferred
8452,1,Solid pseudopapillary tumor (C25._),preferred
8452,1,Papillary cystic tumor,alternate
8452,1,Solid and papillary epithelial neoplasm,alternate
8452,1,Solid and cystic tumor,alternate
8452,3,Solid pseudopapillary carcinoma (C25._),preferred
8452,3,Solid pseudopapillary neoplasm of the pancreas (C25._),alternate
8453,0,Intraductal papillary-mucinous adenoma (C25._),preferred
8453,1,Intraductal papillary-mucinous tumor with moderate dysplasia (C25._),preferred
8453,2,"Intraductal papillary-mucinous carcinoma, non-invasive (C25._)",preferred
8453,2,IPMN with high grade dysplasia,alternate
8453,2,Intraductal papillary mucinous neoplasm with high-grade dysplasia (C25._),alternate
8453,3,"Intraductal papillary-mucinous carcinoma, invasive (C25._)",preferred
8453,3,Intraductal papillary mucinous neoplasm with high grade dysplasia,alternate
8453,3,Intraductal papillary mucinous neoplasm (IPMN) with an associated invasive  carcinoma (C25._),alternate
8454,0,Cystic tumor of atrio-ventricular node (C38.0),preferred
8460,0,"Papillary serous cystadenoma, NOS (C56.9)",preferred
8460,2,"Papillary serous cystadenocarcinoma in situ, NOS (C56.9)",preferred
8460,2,Non-invasive low grade serous carcinoma (C56.9),alternate
8460,2,Serous borderline tumor-micropapillary variant (C56.9),alternate
8460,3,Papillary serous cystadenocarcinoma (C56.9),preferred
8460,3,"Low-grade serous carcinoma (C56.9, C48._, C57.0, C57.1–C57.3)",alternate
8460,3,Papillary serous adenocarcinoma,alternate
8460,3,Micropapillary serous carcinoma,alternate
8461,0,Serous surface papilloma (C56.9),preferred
8461,2,"Serous surface papilloma, in situ (C56.9)",preferred
8461,3,Serous surface papillary carcinoma (C56.9),preferred
8461,3,"High-grade serous carcinoma (C48._, C56.9, C57.0, C57.1–C57.3)",alternate
8461,3,Primary serous papillary carcinoma of peritoneum,alternate
8462,1,"Serous papillary cystic tumor, borderline malignancy (C56.9)",preferred
8462,1,"Papillary serous cystadenoma, borderline malignancy",alternate
8462,1,Papillary serous tumor of low malignant potential,alternate
8462,1,Atypical proliferative papillary serous tumor,alternate
8463,1,Serous surface papillary tumor of borderline malignancy (C56.9),preferred
8463,3,Serous surface papillary carcinoma (C56.9),preferred
8470,0,Mucinous cystadenoma (C56.9),preferred
8470,0,Mucinous cystoma,alternate
8470,0,"Pseudomucinous cystadenoma, NOS",alternate
8470,1,Mucinous cystic tumor with moderate dysplasia (C25._),preferred
8470,2,"Mucinous cystadenocarcinoma, non-invasive (C25._)",preferred
8470,3,"Mucinous cystadenocarcinoma, NOS (C56.9)",preferred
8470,3,Mucinous cystic tumor with associated invasive carcinoma (C25._),alternate
8470,3,Pseudomucinous adenocarcinoma,alternate
8470,3,"Pseudomucinous cystadenocarcinoma, NOS",alternate
8471,0,"Papillary mucinous cystadenoma, NOS (C56.9)",preferred
8471,0,"Papillary pseudomucinous cystadenoma, NOS",alternate
8471,2,"Papillary mucinous cystadenoca situ, NOS (C56.9)",preferred
8471,3,Papillary mucinous cystadenocarcinoma (C56.9),preferred
8471,3,Papillary pseudomucinous cystadenocarcinoma,alternate
8472,1,Mucinous cystic tumor of borderline malignancy (C56.9),preferred
8472,1,"Mucinous cystadenoma, borderline malignancy",alternate
8472,1,"Pseudomucinous cystadenoma, borderline malignancy",alternate
8472,1,"Mucinous tumor, NOS, of low malignant potential",alternate
8472,1,Atypical proliferative mucinous tumor,alternate
8472,2,Mucinous cystic adenocarcinoma in situ (C56.9),preferred
8472,3,Mucinous cystadenocarcinoma (C56.9),preferred
8473,1,"Papillary mucinous cystadenoma, borderline malignancy (C56.9)",preferred
8473,1,"Papillary pseudomucinous cystadenoma, borderline malignancy",alternate
8473,1,Papillary mucinous tumor of low malignant potential,alternate
8473,2,"Papillary mucinous cystadenoma, in situ (C56.9)",preferred
8473,3,Papillary pseudomucinous cystadenocarcinoma (C56.9),preferred
8474,3,Seromucinous carcinoma (C56.9),preferred
8480,0,Mucinous adenoma,preferred
8480,1,Low grade appendiceal mucinous neoplasm (C18.1),preferred
8480,2,Mucinous adenocarcinoma in situ,preferred
8480,3,Mucinous adenocarcinoma,preferred
8480,3,Mucinous tubular and spindle cell carcinoma (C64.9),alternate
8480,3,Mucinous carcinoma,alternate
8480,3,Colloid adenocarcinoma,alternate
8480,3,Colloid carcinoma,alternate
8480,3,Gelatinous adenocarcinoma,alternate
8480,3,Gelatinous carcinoma,alternate
8480,3,Mucoid adenocarcinoma,alternate
8480,3,Mucoid carcinoma,alternate
8480,3,Mucous adenocarcinoma,alternate
8480,3,Mucous carcinoma,alternate
8480,3,Pseudomyxoma peritonei with unknown primary site,alternate
8480,6,Pseudomyxoma peritonei (C48.2),preferred
8481,2,Mucin-producing adenocarcinoma in situ,preferred
8481,3,Mucin-producing adenocarcinoma,preferred
8481,3,Mucin-producing carcinoma,alternate
8481,3,Mucin-secreting adenocarcinoma,alternate
8481,3,Mucin-secreting carcinoma,alternate
8482,3,"Mucinous adenocarcinoma, endocervical type",preferred
8482,3,"Mucinous carcinoma, gastric type (C53._)",alternate
8490,0,"Signet ring cell tumor, benign",preferred
8490,2,Signet ring cell carcinoma in situ,preferred
8490,3,Signet ring cell carcinoma,preferred
8490,3,Poorly cohesive carcinoma,alternate
8490,3,Signet ring cell adenocarcinoma,alternate
8490,6,Metastatic signet ring cell carcinoma (C56.9),preferred
8500,2,"Intraductal carcinoma, noninfiltrating, NOS (C50._)",preferred
8500,2,"Intraductal adenocarcinoma, noninfiltrating, NOS",alternate
8500,2,"Intraductal carcinoma, NOS",alternate
8500,2,"Ductal carcinoma in situ, NOS",alternate
8500,2,"DCIS, NOS",alternate
8500,2,Ductal intraepithelial neoplasia 3,alternate
8500,2,DIN 3,alternate
8500,2,"Low grade cribriform cystadenocarcinoma (LGCCC) (C06.9, C08.9)",alternate
8500,2,"Mammary carcinoma, in situ  (C50._)",alternate
8500,2,Non-invasive mammary carcinoma (C50._),alternate
8500,3,Invasive carcinoma of no special type (C50._),preferred
8500,3,"Infiltrating duct carcinoma, NOS (C50._)",alternate
8500,3,"Salivary duct carcinoma (C06.9, C08.9)",alternate
8500,3,"Invasive carcinoma, NST (C50._)",alternate
8500,3,Invasive mammary carcinoma (C50._),alternate
8500,3,Infiltrating duct adenocarcinoma,alternate
8500,3,"Duct adenocarcinoma, NOS",alternate
8500,3,"Duct carcinoma, NOS",alternate
8500,3,Duct cell carcinoma,alternate
8500,3,"Ductal carcinoma, NOS",alternate
8501,2,"Comedocarcinoma, noninfiltrating (C50._)",preferred
8501,2,"DCIS, comedo type",alternate
8501,2,"Ductal carcinoma in situ, comedo type",alternate
8501,3,"Comedocarcinoma, NOS (C50._)",preferred
8502,2,"Secretory carcinoma of breast, in situ (C50._)",preferred
8502,3,Secretory carcinoma of breast (C50._),preferred
8502,3,Juvenile carcinoma of breast,alternate
8503,0,Intraductal papilloma (C50._),preferred
8503,0,"Duct adenoma, NOS",alternate
8503,0,Ductal papilloma,alternate
8503,2,Noninfiltrating intraductal papillary adenocarcinoma (C50._),preferred
8503,2,Noninfiltrating intraductal papillary carcinoma,alternate
8503,2,"Intraductal papillary adenocarcinoma, NOS",alternate
8503,2,"Intraductal papillary carcinoma, NOS",alternate
8503,2,"Ductal carcinoma in situ, papillary",alternate
8503,2,"DCIS, papillary",alternate
8503,2,Intraductal papilloma with ductal carcinoma in situ (C50._),alternate
8503,2,Intraductal tubulopapillary neoplasm (C25._),alternate
8503,3,Intraductal papillary adenocarcinoma with invasion (C50._),preferred
8503,3,Infiltrating papillary adenocarcinoma,alternate
8503,3,Infiltrating and papillary adenocarcinoma,alternate
8503,3,Intracystic papillary neoplasm with associated invasive carcinoma,alternate
8504,0,Intracystic papillary adenoma,preferred
8504,0,Intracystic papilloma,alternate
8504,2,Noninfiltrating intracystic carcinoma,preferred
8504,2,Encapsulated papillary carcinoma C50._),alternate
8504,3,"Intracystic carcinoma, NOS",preferred
8504,3,Encapsulated papillary carcinoma with invasion (C50._),alternate
8504,3,Intracystic papillary adenocarcinoma,alternate
8505,0,"Intraductal papillomatosis, NOS",preferred
8505,0,Diffuse intraductal papillomatosis,alternate
8506,0,Adenoma of nipple (C50._),preferred
8506,0,Subareolar duct papillomatosis,alternate
8507,2,Intraductal micropapillary carcinoma (C50._),preferred
8507,2,"Intraductal carcinoma, clinging",alternate
8507,2,"Ductal carcinoma in situ, micropapillary",alternate
8507,3,Invasive micropapillary carcinoma (C50._),preferred
8507,3,"Ductal carcinoma, micropapillary (C50._)",alternate
8508,2,"Cystic hypersecretory carcinoma, in situ (C50._)",preferred
8508,3,Cystic hypersecretory carcinoma (C50._),preferred
8509,2,Solid papillary carcinoma in situ (C50._),preferred
8509,3,Solid papillary carcinoma with invasion (C50._),preferred
8510,2,"Medullary carcinoma in situ, NOS (C73.9)",preferred
8510,3,"Medullary carcinoma, NOS (C73.9)",preferred
8510,3,Medullary adenocarcinoma,alternate
8510,3,Renal medullary carcinoma (C64.9),alternate
8512,2,Medullary carcinoma in situ with lymphoid stroma (C50._),preferred
8512,3,Medullary carcinoma with lymphoid stroma (C50._),preferred
8513,3,Atypical medullary carcinoma (C50._),preferred
8514,3,"Duct carcinoma, desmoplastic type (C50._)",preferred
8519,2,Pleomorphic lobular carcinoma in situ (C50._),preferred
8520,2,Lobular carcinoma in situ (C50._),preferred
8520,2,"Lobular carcinoma, noninfiltrating",alternate
8520,2,"LCIS, NOS",alternate
8520,2,Intraductal papilloma with lobular carcinoma in situ (C50._),alternate
8520,2,Lobular intraepithelial neoplasia grade 3,alternate
8520,3,"Lobular carcinoma, NOS (C50._)",preferred
8520,3,Lobular adenocarcinoma,alternate
8520,3,"Invasive lobular carcinoma, alveolar type (C50._)",alternate
8520,3,"Invasive lobular carcinoma, solid type (C50._)",alternate
8520,3,"Invasive lobular carcinoma, tubulolobular variant (C50._)",alternate
8520,3,Pleomorphic lobular carcinoma (C50._),alternate
8520,3,Invasive lobular carcinoma (C50._),alternate
8520,3,Tubulolobular carcinoma (C50._),alternate
8520,3,"Infiltrating lobular carcinoma, NOS",alternate
8521,2,Ductular carcinoma in situ (C50._),preferred
8521,3,Infiltrating ductular carcinoma (C50._),preferred
8522,2,Intraductal and lobular in situ carcinoma (C50._),preferred
8522,3,Infiltrating duct and lobular carcinoma (C50._),preferred
8522,3,Intraductal and lobular carcinoma,alternate
8522,3,Infiltrating lobular carcinoma and ductal carcinoma in situ,alternate
8522,3,Lobular and ductal carcinoma,alternate
8522,3,Infiltrating duct and lobular carcinoma in situ,alternate
8523,2,Intraductal with other types of carcinoma in situ (C50._),preferred
8523,3,Infiltrating duct mixed with other types of carcinoma (C50._),preferred
8523,3,Infiltrating duct and cribriform carcinoma,alternate
8523,3,Infiltrating duct and mucinous carcinoma,alternate
8523,3,Infiltrating duct and tubular carcinoma,alternate
8523,3,Infiltrating duct and colloid carcinoma,alternate
8524,2,"Infiltrating lobular mixed with other types of carcinoma, in situ (C50._)",preferred
8524,3,Infiltrating lobular mixed with other types of carcinoma (C50._),preferred
8525,3,Polymorphous low grade adenocarcinoma,preferred
8525,3,Terminal duct adenocarcinoma,alternate
8530,3,Inflammatory carcinoma (C50._),preferred
8530,3,Inflammatory adenocarcinoma,alternate
8540,2,"Paget disease, mammary in situ (C50._)",preferred
8540,3,"Paget disease, mammary (C50._)",preferred
8540,3,Paget disease of breast,alternate
8541,3,Paget disease and infiltrating ductal carcinoma of breast (C50._),preferred
8542,2,"Paget disease (in situ), extramammary (except Paget disease of bone) (C50._)",preferred
8542,3,"Paget disease, extramammary (except Paget disease of bone)",preferred
8543,2,Paget disease in situ and intraductal carcinoma (C50._),preferred
8543,3,Paget disease and intraductal carcinoma (C50._),preferred
8550,0,Acinar cell adenoma,preferred
8550,0,Acinar adenoma,alternate
8550,0,Acinic cell adenoma,alternate
8550,1,Acinar cell tumor [obs],preferred
8550,1,Acinic cell tumor,alternate
8550,2,Acinar cell carcinoma in situ,preferred
8550,3,Acinar cell carcinoma,preferred
8550,3,Acinar cell carcinoma,alternate
8550,3,Acinic cell adenocarcinoma,alternate
8550,3,Acinar adenocarcinoma,alternate
8550,3,Acinar carcinoma,alternate
8551,3,Acinar cell cystadenocarcinoma,preferred
8551,3,Acinar adenocarcinoma (C34._),alternate
8552,3,Mixed acinar ductal carcinoma,preferred
8560,0,Mixed squamous cell and glandular papilloma,preferred
8560,2,Squamous cell carcinoma in situ and glandular papilloma,preferred
8560,3,Adenosquamous carcinoma,preferred
8560,3,Mixed adenocarcinoma and epidermoid carcinoma,alternate
8560,3,Mixed adenocarcinoma and squamous cell carcinoma,alternate
8561,0,"Adenolymphoma (C07._, C08._)",preferred
8561,0,Papillary cystadenoma lymphomatosum,alternate
8561,0,Warthin tumor,alternate
8561,3,"Warthin tumor, malignant (C07._, C08._)",preferred
8562,2,Epithelial-myoepithelial carcinoma in situ,preferred
8562,3,Epithelial-myoepithelial carcinoma,preferred
8570,2,Adenocarcinoma in situ with squamous metaplasia,preferred
8570,3,Adenocarcinoma with squamous metaplasia,preferred
8570,3,Adenoacanthoma,alternate
8570,3,"Endometrioid carcinoma with squamous differentiation (C54._, C55.9)",alternate
8570,3,Low grade adenosquamous carcinoma (C50._),alternate
8571,2,"Adenocarcinoma in situ, cartilaginous and osseous metaplasia",preferred
8571,3,Adenocarcinoma with cartilaginous and osseous metaplasia,preferred
8571,3,Metaplastic carcinoma with chondroid differentiation (C50._),alternate
8571,3,Metaplastic carcinoma with osseous differentiation (C50._),alternate
8571,3,Adenocarcinoma with cartilaginous metaplasia,alternate
8571,3,Adenocarcinoma with osseous metaplasia,alternate
8571,3,Carcinoma with chondroid differentiation (C50._),alternate
8571,3,Carcinoma with osseous differentiation (C50._),alternate
8572,0,Adenoma with spindle cell metaplasia,preferred
8572,3,Adenocarcinoma with spindle cell metaplasia,preferred
8572,3,"Acinar adenocarcinoma, sarcomatoid (C61.9)",alternate
8572,3,Fibromatosis-like metaplastic carcinoma (C50._),alternate
8573,2,Adenocarcinoma in situ with apocrine metaplasia,preferred
8573,3,Adenocarcinoma with apocrine metaplasia,preferred
8573,3,Carcinoma with apocrine metaplasia,alternate
8574,2,Adenocarcinoma in situ with neuroendocrine differentiation,preferred
8574,3,Adenocarcinoma with neuroendocrine differentiation,preferred
8574,3,Adenocarcinoma admixed with neuroendocrine carcinoma (C53._),alternate
8574,3,Carcinoma with neuroendocrine differentiation,alternate
8575,3,"Metaplastic carcinoma, NOS",preferred
8575,3,Carcinoma with other types mesenchymal differentiation (C50._),alternate
8575,3,Metaplastic carcinoma with other types mesenchymal differentiation (C50._),alternate
8575,3,Metaplastic carcinoma of no special type (C50._),alternate
8576,3,Hepatoid adenocarcinoma,preferred
8576,3,Hepatoid carcinoma,alternate
8580,0,"Thymoma, benign (C37.9)",preferred
8580,1,"Thymoma, NOS (C37.9)",preferred
8580,2,"Thymoma, in situ, NOS (C37.9)",preferred
8580,3,"Thymoma, malignant, NOS (C37.9)",preferred
8581,1,"Thymoma, type A, NOS (C37.9)",preferred
8581,1,"Thymoma, spindle cell, NOS",alternate
8581,1,"Thymoma, medullary, NOS",alternate
8581,3,"Thymoma, type A, malignant (C37.9)",preferred
8581,3,"Thymoma, spindle cell, malignant",alternate
8581,3,"Thymoma, medullary, malignant",alternate
8582,1,"Thymoma, type AB, NOS (C37.9)",preferred
8582,1,"Thymoma, mixed type, NOS",alternate
8582,3,"Thymoma, type AB, malignant (C37.9)",preferred
8582,3,"Thymoma, mixed type, malignant",alternate
8583,1,"Thymoma, type B1, NOS (C37.9)",preferred
8583,1,"Thymoma, lymphocytic, NOS",alternate
8583,1,"Thymoma, predominantly cortical, NOS",alternate
8583,1,"Thymoma, organoid, NOS",alternate
8583,1,"Thymoma, lymphocyte-rich, NOS",alternate
8583,3,"Thymoma, type B1, malignant (C37.9)",preferred
8583,3,"Thymoma, lymphocyte-rich, malignant",alternate
8583,3,"Thymoma, lymphocytic, malignant",alternate
8583,3,"Thymoma, predominantly cortical, malignant",alternate
8583,3,"Thymoma, organoid, malignant",alternate
8584,1,"Thymoma, type B2, NOS (C37.9)",preferred
8584,1,"Thymoma, cortical, NOS",alternate
8584,3,"Thymoma, type B2, malignant (C37.9)",preferred
8584,3,"Thymoma, cortical, malignant",alternate
8585,1,"Thymoma, type B3, NOS (C37.9)",preferred
8585,1,"Thymoma, epithelial, NOS",alternate
8585,1,"Thymoma, atypical, NOS",alternate
8585,3,"Thymoma, type B3, malignant (C37.9)",preferred
8585,3,"Thymoma, epithelial, malignant",alternate
8585,3,"Thymoma, atypical, malignant",alternate
8585,3,Well differentiated thymic carcinoma,alternate
8586,3,"Thymic carcinoma, NOS (C37.9)",preferred
8586,3,"Thymoma, type C",alternate
8587,0,Ectopic hamartomatous thymoma (C37.9),preferred
8588,3,Spindle epithelial tumor with thymus-like element (C37.9),preferred
8588,3,SETTLE,alternate
8588,3,Spindle epithelial tumor with thymus-like differentiation,alternate
8589,3,Carcinoma showing thymus-like element (C37.9),preferred
8589,3,Carcinoma showing thymus-like differentiation,alternate
8589,3,CASTLE,alternate
8590,1,"Sex cord-gonadal stromal tumor, NOS (C56.9 [F], C62._[M])",preferred
8590,1,"Gonadal stromal tumor, NOS",alternate
8590,1,Testicular stromal tumor,alternate
8590,1,Ovarian stromal tumor,alternate
8590,1,"Sex cord tumor, NOS",alternate
8590,3,"Sex cord-gonadal stromal tumor, malignant, NOS (C56.9 [F], C62._[M])",preferred
8591,1,"Sex cord-gonadal stromal tumor, incompletely differentiated (C56.9 [F], C62._[M])",preferred
8592,1,"Sex cord-gonadal stromal tumor, mixed forms (C56.9 [F], C62._[M])",preferred
8593,1,Stromal tumor with minor sex cord elements (C56.9),preferred
8593,3,"Malignant stromal tumor, with sex cord elements (C56.9)",preferred
8594,1,"Mixed germ cell sex cord-stromal tumor, unclassified (C48.2, C56.9, C57.9)",preferred
8600,0,"Thecoma, NOS (C56.9)",preferred
8600,0,Theca cell tumor,alternate
8600,3,"Thecoma, malignant (C56.9)",preferred
8601,0,"Thecoma, luteinized (C56.9)",preferred
8602,0,Sclerosing stromal tumor (C56.9),preferred
8602,3,"Sclerosing stromal tumor, malignant (C56.9)",preferred
8610,0,"Luteoma, NOS (C56.9)",preferred
8610,0,Luteinoma,alternate
8620,1,"Granulosa cell tumor, adult type (C56.9)",preferred
8620,1,"Granulosa cell tumor, NOS",alternate
8620,3,"Granulosa cell tumor, malignant (C56.9 )",preferred
8620,3,Adult granulosa cell tumor (C56.9 ONLY),alternate
8620,3,Granulosa cell carcinoma,alternate
8620,3,"Granulosa cell tumor, sarcomatoid",alternate
8621,1,Granulosa cell-theca cell tumor (C56.9),preferred
8621,1,Theca cell-granulosa cell tumor,alternate
8621,3,"Granulosa cell-theca cell tumor, malignant (C56.9)",preferred
8622,1,"Granulosa cell tumor, juvenile (C56.9)",preferred
8622,3,"Juvenile granulosa cell tumor, malignant (C56.9)",preferred
8623,1,Sex cord tumor with annular tubules (C56.9),preferred
8623,3,"Sex cord tumor with annular tubules, malignant (C56.9)",preferred
8630,0,"Androblastoma, benign (C56.9 [F], C62._[M])",preferred
8630,0,"Arrhenoblastoma, benign",alternate
8630,1,"Androblastoma, NOS (C56.9 [F], C62._[M])",preferred
8630,1,"Arrhenoblastoma, NOS",alternate
8630,3,"Androblastoma, malignant (C56.9 [F], C62._[M])",preferred
8630,3,"Arrhenoblastoma, malignant",alternate
8631,0,"Sertoli-Leydig cell tumor, well differentiated (C56.9 [F], C62._[M])",preferred
8631,1,"Sertoli-Leydig cell tumor of intermediate differentiation (C56.9 [F], C62._[M])",preferred
8631,1,"Sertoli-Leydig cell tumor, NOS",alternate
8631,3,"Sertoli-Leydig cell tumor, poorly differentiated (C56.9 [F], C62._[M])",preferred
8631,3,"Sertoli-Leydig cell tumor, sarcomatoid",alternate
8632,1,"Gynandroblastoma (C56.9 [F], C62._[M])",preferred
8632,3,"Gynandroblastoma, malignant (C56.9 [F], C62._[M])",preferred
8633,1,"Sertoli-Leydig cell tumor, retiform (C56.9 [F], C62._[M])",preferred
8634,1,"Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements",preferred
8634,1,"Sertoli-Leydig cell tumor, retiform, with heterologous elements",alternate
8634,3,"Sertoli-Leydig cell tumor, poorly differentiated with heterologous elements (C56.9 [F], C62._[M])",preferred
8640,1,"Sertoli cell tumor, NOS (C56.9 [F], C62._[M])",preferred
8640,1,Pick tubular adenoma,alternate
8640,1,Sertoli cell adenoma,alternate
8640,1,"Tubular androblastoma, NOS",alternate
8640,1,Testicular adenoma,alternate
8640,3,"Sertoli cell carcinoma (C56.9 [F], C62._[M])",preferred
8641,0,"Sertoli cell tumor with lipid storage (C56.9 [F], C62._[M])",preferred
8641,0,Folliculome lipidique,alternate
8641,0,Tubular androblastoma with lipid storage,alternate
8641,0,Lipid-rich Sertoli cell tumor,alternate
8642,1,"Large cell calcifying Sertoli cell tumor (C56.9 [F], C62._[M])",preferred
8650,0,"Leydig cell tumor, benign (C56.9 [F], C62._[M])",preferred
8650,0,"Interstitial cell tumor, benign",alternate
8650,1,"Leydig cell tumor, NOS (C56.9 [F], C62._[M])",preferred
8650,1,"Interstitial cell tumor, NOS",alternate
8650,3,"Leydig cell tumor, malignant (C56.9 [F], C62._[M])",preferred
8650,3,"Interstitial cell tumor, malignant",alternate
8660,0,Hilus cell tumor (C56.9),preferred
8660,0,Hilar cell tumor,alternate
8670,0,Lipid cell tumor of ovary (C56.9),preferred
8670,0,Masculinovoblastoma,alternate
8670,0,Lipoid cell tumor of ovary,alternate
8670,0,"Steroid cell tumor, NOS",alternate
8670,3,"Steroid cell tumor, malignant (C56.9)",preferred
8671,0,Adrenal rest tumor,preferred
8680,0,"Paraganglioma, benign (C75.5)",preferred
8680,1,"Paraganglioma, NOS (C75.5)",preferred
8680,3,"Paraganglioma, malignant (C75.5)",preferred
8681,1,Sympathetic paraganglioma (C75.5),preferred
8682,1,Parasympathetic paraganglioma (C75.5),preferred
8683,0,Gangliocytic paraganglioma (C17.0),preferred
8683,3,"Gangliocytic paraganglioma, malignant (C17.0)",preferred
8690,1,"Glomus jugulare tumor, NOS (C75.5)",preferred
8690,1,Jugular paraganglioma,alternate
8690,1,Jugulotympanic paraganglioma,alternate
8690,3,"Glomus jugulare tumor, malignant (C75.5)",preferred
8691,1,Aortic body tumor (C75.5),preferred
8691,1,Aortic body paraganglioma,alternate
8691,1,Aorticopulmonary paraganglioma,alternate
8691,3,"Aortic body tumor, malignant (C75.5)",preferred
8692,1,Carotid body tumor (C75.4),preferred
8692,1,Carotid body paraganglioma,alternate
8692,3,"Carotid body tumor, malignant (C75.4)",preferred
8693,1,"Extra-adrenal paraganglioma, NOS (C75.5)",preferred
8693,1,"Nonchromaffin paraganglioma, NOS",alternate
8693,1,Chemodectoma,alternate
8693,3,"Extra-adrenal paraganglioma, malignant (C75.5)",preferred
8693,3,"Nonchromaffin paraganglioma, malignant",alternate
8700,0,"Pheochromocytoma, NOS (C74.1)",preferred
8700,0,Adrenal medullary paraganglioma,alternate
8700,0,Chromaffin paraganglioma,alternate
8700,0,Chromaffin tumor,alternate
8700,0,Chromaffinoma,alternate
8700,3,"Pheochromocytoma, malignant (C74.1)",preferred
8700,3,"Adrenal medullary paraganglioma, malignant",alternate
8700,3,Pheochromoblastoma,alternate
8710,3,Glomangiosarcoma (C49._),preferred
8710,3,Glomoid sarcoma,alternate
8711,0,"Glomus tumor, NOS",preferred
8711,3,"Glomus tumor, malignant (C49._)",preferred
8712,0,Glomangioma,preferred
8712,3,"Glomangioma, malignant (C49._)",preferred
8713,0,Glomangiomyoma,preferred
8714,3,"PEComa, malignant",preferred
8714,3,Malignant perivascular epithelial cell tumor,alternate
8714,3,"Perivascular epithelioid cell tumor, malignant",alternate
8720,0,"Pigmented nevus, NOS (C44._)",preferred
8720,0,"Nevus, NOS",alternate
8720,0,Melanocytic nevus,alternate
8720,0,Hairy nevus,alternate
8720,2,Melanoma in situ (C44._),preferred
8720,3,"Malignant melanoma, NOS (C44._)",preferred
8720,3,"Melanoma, NOS",alternate
8720,3,"Meningeal melanoma (C70._, C71._)",alternate
8721,2,"Nodular melanoma, in situ (C44._)",preferred
8721,3,Nodular melanoma (C44._),preferred
8722,0,Balloon cell nevus (C44._),preferred
8722,2,"Balloon cell melanoma, in situ (C44._)",preferred
8722,3,Balloon cell melanoma (C44._),preferred
8723,0,Halo nevus (C44._),preferred
8723,0,Regressing nevus,alternate
8723,2,"Melanoma in situ, regressing (C44._)",preferred
8723,3,"Malignant melanoma, regressing (C44._)",preferred
8725,0,Neuronevus (C44._),preferred
8726,0,Magnocellular nevus (C69.4),preferred
8726,0,"Melanocytoma, eyeball",alternate
8726,0,"Melanocytoma, NOS",alternate
8726,3,Malignant melanoma in magnocellular nevus (C69.4),preferred
8727,0,Dysplastic nevus ( C44._),preferred
8727,3,"Dysplastic nevus, malignant (C44._)",preferred
8728,0,Diffuse melanocytosis (C70.9),preferred
8728,1,Meningeal melanocytoma (C70.9),preferred
8728,3,Meningeal melanomastosis (C70.9),preferred
8730,0,Nonpigmented nevus (C44._),preferred
8730,0,Achromic nevus,alternate
8730,2,Amelanotic melanoma,preferred
8730,3,Amelanotic melanoma (C44._),preferred
8740,0,"Junctional nevus, NOS (C44._)",preferred
8740,0,Junction nevus,alternate
8740,0,Intraepidermal nevus,alternate
8740,2,Melanoma in situ in junctional nevus (C44._),preferred
8740,3,Malignant melanoma in junctional nevus (C44._),preferred
8741,2,"Precancerous melanosis, NOS (C44._)",preferred
8741,3,Malignant melanoma in precancerous melanosis (C44._),preferred
8742,2,Lentigo maligna (C44._),preferred
8742,2,"Hutchinson melanotic freckle, NOS",alternate
8742,3,Lentigo maligna melanoma (C44._),preferred
8742,3,Malignant melanoma in Hutchinson melanotic freckle,alternate
8743,2,Superficial spreading melanoma in situ (C44._),preferred
8743,3,Superficial spreading melanoma (C44._),preferred
8744,2,"Acral lentiginous melanoma, in situ (C44._)",preferred
8744,3,"Acral lentiginous melanoma, in malignant (C44._)",preferred
8745,2,"Desmoplastic melanoma, in situ (C44._)",preferred
8745,3,"Desmoplastic melanoma, malignant (C44._)",preferred
8745,3,"Neurotropic melanoma, malignant",alternate
8745,3,"Desmoplastic melanoma, amelanotic",alternate
8746,2,Mucosal lentiginous melanoma in situ (C44._),preferred
8746,3,Mucosal lentiginous melanoma (C44._),preferred
8750,0,Intradermal nevus (C44._),preferred
8750,0,Dermal nevus,alternate
8760,0,Compound nevus (C44._),preferred
8760,0,Dermal and epidermal nevus,alternate
8760,2,Melanoma in situ in compound nevus (C44._),preferred
8761,0,Small congenital nevus (C44._),preferred
8761,1,"Giant pigmented nevus, NOS (C44._)",preferred
8761,1,Intermediate and giant congenital nevus,alternate
8761,2,Melanoma in situ in giant pigmented nevus (C44._),preferred
8761,3,Malignant melanoma in giant pigmented nevus (C44._),preferred
8761,3,Malignant melanoma in congenital melanocytic nevus,alternate
8762,1,Proliferative dermal lesion in congenital nevus (C44._),preferred
8770,0,Epithelioid and spindle cell nevus (C44._),preferred
8770,0,Juvenile nevus,alternate
8770,0,Juvenile melanoma,alternate
8770,0,Spitz nevus,alternate
8770,0,Pigmented spindle cell nevus of Reed,alternate
8770,2,Epithelioid and spindle cell melanoma in situ (C44._),preferred
8770,3,Mixed epithelioid and spindle cell melanoma (C44._),preferred
8771,0,Epithelioid cell nevus (C44._),preferred
8771,2,Epithelioid cell melanoma in situ (C44._),preferred
8771,3,Epithelioid cell melanoma (C44._),preferred
8772,0,"Spindle cell nevus, NOS (C44._)",preferred
8772,2,"Spindle cell melanoma in situ, NOS (C44._)",preferred
8772,3,"Spindle cell melanoma, NOS (C44._)",preferred
8773,3,"Spindle cell melanoma, type A (C69._)",preferred
8774,3,"Spindle cell melanoma, type B (C69._)",preferred
8780,0,"Blue nevus, NOS (C44._)",preferred
8780,0,Jadassohn blue nevus,alternate
8780,3,"Blue nevus, malignant (C44._)",preferred
8790,0,Cellular blue nevus (C44._),preferred
8790,3,"Cellular blue nevus, malignant (C44._)",preferred
8800,0,"Soft tissue tumor, benign (C49._)",preferred
8800,3,"Sarcoma, NOS (C49._)",preferred
8800,3,Soft tissue sarcoma,alternate
8800,3,"Soft tissue tumor, malignant",alternate
8800,3,"Mesenchymal tumor, malignant",alternate
8800,9,"Sarcomatosis, NOS (C47._, C49._)",preferred
8801,3,Spindle cell sarcoma (C49._),preferred
8801,3,Undifferentiated spindle cell sarcoma,alternate
8802,3,Giant cell sarcoma (C49._),preferred
8802,3,Pleomorphic cell sarcoma,alternate
8802,3,Undifferentiated pleomorphic sarcoma,alternate
8803,3,Small cell sarcoma (C49._),preferred
8803,3,Round cell sarcoma,alternate
8803,3,Undifferentiated round cell sarcoma,alternate
8804,3,Epithelioid sarcoma (C49._),preferred
8804,3,Epithelioid cell sarcoma,alternate
8804,3,Undifferentiated epithelioid sarcoma,alternate
8805,3,Undifferentiated sarcoma (C49._),preferred
8805,3,Undifferentiated uterine sarcoma,alternate
8806,3,Desmoplastic small round cell tumor (C49._),preferred
8810,0,"Fibroma, NOS (C49._)",preferred
8810,1,Cellular fibroma (C56.9),preferred
8810,3,"Fibrosarcoma, NOS (C49._)",preferred
8811,0,Fibromyxoma (C49._),preferred
8811,0,Plexiform fibromyxoma,alternate
8811,0,Myxoid fibroma,alternate
8811,0,"Myxofibroma, NOS",alternate
8811,1,Myxoinflammatory fibroblastic sarcoma (MIFS) (C49._),preferred
8811,3,Fibromyxosarcoma (C49._),preferred
8812,0,"Periosteal fibroma (C40._, C41._)",preferred
8812,3,"Periosteal fibrosarcoma (C40._,C41._)",preferred
8812,3,"Periosteal sarcoma, NOS",alternate
8813,0,Fascial fibroma (C49._),preferred
8813,3,Fascial fibrosarcoma (C49._),preferred
8814,3,Infantile fibrosarcoma (C49._),preferred
8814,3,Congenital fibrosarcoma,alternate
8815,0,Solitary fibrous tumor (C49._),preferred
8815,0,Localized fibrous tumor,alternate
8815,0,Solitary fibrous tumor/hemangiopericytoma Grade 1 (CNS) (C71._),alternate
8815,1,Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS) (C71._),preferred
8815,3,"Solitary fibrous tumor, malignant (C49._)",preferred
8815,3,Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS) (C71._),alternate
8820,0,Elastofibroma (C49._),preferred
8821,1,Aggressive fibromatosis (C49._),preferred
8821,1,Extra-abdominal desmoid,alternate
8821,1,"Desmoid, NOS",alternate
8821,1,Invasive fibroma,alternate
8821,3,"Aggressive fibromatosis, malignant (C49._)",preferred
8822,1,Abdominal fibromatosis (C49._),preferred
8822,1,Abdominal desmoid,alternate
8822,1,Mesenteric fibromatosis,alternate
8822,1,Retroperitoneal fibromatosis,alternate
8822,3,"Abdominal fibrosis, malignant (C49._)",preferred
8823,0,"Desmoplastic fibroma, benign (C49._)",preferred
8823,1,Desmoplastic fibroma (C49._),preferred
8823,3,Desmoplastic fibrosarcoma (C49._),preferred
8824,0,Myofibroma (C49._),preferred
8824,1,Myofibromatosis (C49._),preferred
8824,1,Congenital generalized fibromatosis,alternate
8824,1,Infantile myofibromatosis,alternate
8824,3,"Myofibroma, malignant (C49._)",preferred
8825,0,Myofibroblastoma (C49._),preferred
8825,1,"Myofibroblastic tumor, NOS (C49._)",preferred
8825,1,Inflammatory myofibroblastic tumor,alternate
8825,3,Myofibroblastic sarcoma,preferred
8825,3,"Low-grade myofibroblastic sarcoma ( C01.9, C02._, C06.9, C49._)",alternate
8826,0,Angiomyofibroblastoma (C49._),preferred
8826,3,"Angiomyofibroblastoma, malignant (C49._)",preferred
8827,1,"Myofibroblastic tumor, peribronchial (C34._)",preferred
8827,1,Congenital peribronchial myofibroblastic tumor,alternate
8830,0,Benign fibrous histiocytoma (C49._),preferred
8830,0,"Fibrous histiocytoma, NOS",alternate
8830,0,"Fibroxanthoma, NOS",alternate
8830,0,Xanthofibroma,alternate
8830,1,Atypical fibrous histiocytoma (C49._),preferred
8830,1,Atypical fibroxanthoma,alternate
8830,3,Malignant fibrous histiocytoma (C49._),preferred
8830,3,"Fibroxanthoma, malignant",alternate
8830,3,Malignant fibrous histiocytoma (MFH) of bone,alternate
8830,3,Undifferentiated high-grade pleomorphic sarcoma,alternate
8831,0,"Histiocytoma, NOS (C49._)",preferred
8831,0,Deep histiocytoma,alternate
8831,0,Juvenile histiocytoma,alternate
8831,0,Reticulohistiocytoma,alternate
8831,3,"Histiocytoma, NOS, malignant (C49._)",preferred
8832,0,"Dermatofibroma, NOS (C44._)",preferred
8832,0,Sclerosing hemangioma,alternate
8832,0,"Cutaneous histiocytoma, NOS",alternate
8832,0,Subepidermal nodular fibrosis,alternate
8832,0,Dermatofibroma lenticulare,alternate
8832,3,"Dermatofibrosarcoma, NOS (C44._)",preferred
8832,3,Fibrosarcomatous dermatofibrosarcoma protuberans,alternate
8832,3,"Dermatofibrosarcoma protuberans, NOS",alternate
8833,3,Pigmented dermatofibrosarcoma protuberans (C44._),preferred
8833,3,Bednar tumor,alternate
8834,1,Giant cell fibroblastoma,preferred
8835,1,Plexiform fibrohistiocytic tumor,preferred
8835,3,Malignant plexiform fibrohistiocytic tumor,preferred
8836,1,Angiomatoid fibrous histiocytoma,preferred
8836,3,Malignant angiomatoid fibrous histiocytoma,preferred
8840,0,"Myxoma, NOS (C49._)",preferred
8840,3,Myxosarcoma (C49._),preferred
8840,3,Low-grade fibromyxoid sarcoma,alternate
8840,3,Sclerosing epithelioid fibrosarcoma,alternate
8841,1,Angiomyxoma (C49._),preferred
8841,1,Aggressive angiomyxoma,alternate
8841,3,"Angiomyxoma, malignant (C49._)",preferred
8842,0,Ossifying fibromyxoid tumor,preferred
8842,3,"Ossifying fibromyxoid tumor, malignant",preferred
8842,3,"Ossifying fibromyxoid tumor, malignant (C49._)",alternate
8842,3,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation (C34._),alternate
8850,0,"Lipoma, NOS",preferred
8850,1,Atypical lipoma,preferred
8850,1,Superficial well differentated liposarcoma,alternate
8850,1,Well differentiated liposarcoma of superficial soft tissue,alternate
8850,3,"Liposarcoma, NOS (C49._)",preferred
8850,3,Fibroliposarcoma,alternate
8851,0,Fibrolipoma,preferred
8851,3,"Liposarcoma, well differentiated (C49._)",preferred
8851,3,"Liposarcoma, differentiated",alternate
8851,3,Lipoma-like liposarcoma,alternate
8851,3,Sclerosing liposarcoma,alternate
8851,3,Inflammatory liposarcoma,alternate
8852,0,Fibromyxolipoma,preferred
8852,0,Myxolipoma,alternate
8852,3,Myxoid liposarcoma (C49._),preferred
8852,3,Myxoliposarcoma,alternate
8853,3,Round cell liposarcoma (C49._),preferred
8854,0,Pleomorphic lipoma,preferred
8854,3,Pleomorphic liposarcoma (C49._),preferred
8855,3,Mixed liposarcoma (C49._),preferred
8856,0,Intramuscular lipoma,preferred
8856,0,Infiltrating lipoma,alternate
8856,0,Infiltrating angiolipoma,alternate
8857,0,Spindle cell lipoma,preferred
8857,3,Fibroblastic liposarcoma (C49._),preferred
8858,3,Dedifferentiated liposarcoma (C49._),preferred
8860,0,Angiomyolipoma,preferred
8860,3,Angiomyoliposarcoma (C49._),preferred
8861,0,"Angiolipoma, NOS",preferred
8862,0,Chondroid lipoma,preferred
8870,0,Myelolipoma,preferred
8880,0,Hibernoma,preferred
8880,0,Fetal fat cell lipoma,alternate
8880,0,Brown fat tumor,alternate
8881,0,Lipoblastomatosis,preferred
8881,0,Fetal lipomatosis,alternate
8881,0,Lipoblastoma,alternate
8881,0,"Fetal lipoma, NOS",alternate
8890,0,"Leiomyoma, NOS (C54._, C55.9)",preferred
8890,0,Fibroid uterus,alternate
8890,0,Fibromyoma,alternate
8890,0,Leiomyofibroma,alternate
8890,0,Plexiform leiomyoma,alternate
8890,0,Lipoleiomyoma,alternate
8890,1,"Leiomyomastosis, NOS (C54._, C55.9)",preferred
8890,1,Intravascular leiomyomatosis,alternate
8890,3,"Leiomyosarcoma, NOS (C54._, C55.9)",preferred
8891,0,Epithelioid leiomyoma (C49._),preferred
8891,0,Leiomyoblastoma,alternate
8891,3,Epithelioid leiomyosarcoma (C49._),preferred
8892,0,Cellular leiomyoma (C49._),preferred
8893,0,Bizarre leiomyoma (C49._),preferred
8893,0,Symplastic leiomyoma,alternate
8893,0,Atypical leiomyoma,alternate
8893,0,Pleomorphic leiomyoma,alternate
8893,3,"Bizarre leiomyoma, malignant (C49._)",preferred
8894,0,Angiomyoma (C49._),preferred
8894,0,Vascular leiomyoma,alternate
8894,0,Angioleiomyoma,alternate
8894,3,Angiomyosarcoma (C49._),preferred
8895,0,Myoma (C49._),preferred
8895,3,Myosarcoma (C49._),preferred
8896,3,Myxoid leiomyosarcoma (C49._),preferred
8897,1,Smooth muscle tumor of uncertain malignant potential (C49._),preferred
8897,1,"Smooth muscle tumor, NOS",alternate
8897,3,Malignant tumor of smooth muscle (C49._),preferred
8898,1,Metastasizing leiomyoma (C49._),preferred
8900,0,"Rhabdomyoma, NOS (C49._)",preferred
8900,3,"Rhabdomyosarcoma, NOS (C49._)",preferred
8900,3,Rhabdosarcoma,alternate
8901,3,"Pleomorphic rhabdomyosarcoma, adult type (C49._)",preferred
8901,3,"Pleomorphic rhabdomyosarcoma, NOS",alternate
8902,3,Mixed type rhabdomyosarcoma (C49._),preferred
8902,3,Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma,alternate
8903,0,Fetal rhabdomyoma (C49._),preferred
8904,0,Adult rhabdomyoma (C49._),preferred
8904,0,Glycogenic rhabdomyoma,alternate
8905,0,"Genital rhabdomyoma (C51._ [F], C62.9 [M])",preferred
8910,3,"Embryonal rhabdomyosarcoma, NOS (C49._)",preferred
8910,3,"Embryonal rhabdomyosarcoma, pleomorphic",alternate
8910,3,Sarcoma botryoides,alternate
8910,3,Botryoid sarcoma,alternate
8912,3,Spindle cell rhabdomyosarcoma (C49._),preferred
8912,3,Sclerosing rhabdomyosarcoma,alternate
8920,3,Alveolar rhabdomyosarcoma (C49._),preferred
8921,3,Rhabdomyosarcoma with ganglionic differentiation (C49._),preferred
8921,3,Ectomesenchymoma,alternate
8930,0,Endometrial stromal nodule (C54.1),preferred
8930,3,"Endometrial stromal sarcoma, NOS (C54.1)",preferred
8930,3,"Endometrial sarcoma, NOS",alternate
8930,3,"Endometrial stromal sarcoma, high grade",alternate
8931,3,"Endometrial stroma sarcoma, low grade (C54.1)",preferred
8931,3,Endolymphatic stromal myosis,alternate
8931,3,Endometrial stromatosis,alternate
8931,3,Stromal endometriosis,alternate
8931,3,"Stromal myosis, NOS",alternate
8932,0,Adenomyoma,preferred
8932,0,Atypical polypoid adenomyoma,alternate
8933,3,Adenosarcoma,preferred
8933,3,"Mullerian adenosarcoma (C54._, C55.9)",alternate
8934,3,Carcinofibroma,preferred
8935,0,"Stromal tumor, benign (C54.1)",preferred
8935,1,"Stromal tumor, NOS (C54.1)",preferred
8935,3,"Stromal sarcoma, NOS (C54.1)",preferred
8936,0,"Gastrointestinal stromal tumor, benign (C26.9)",preferred
8936,0,"GIST, benign",alternate
8936,1,"Gastrointestinal stromal tumor, NOS (C26.9)",preferred
8936,1,"Gastrointestinal stromal tumor, uncertain malignant potential",alternate
8936,1,Gastrointestinal autonomic nerve tumor,alternate
8936,1,GANT,alternate
8936,1,Gastrointestinal pacemaker cell tumor,alternate
8936,1,"GIST, NOS",alternate
8936,2,"Gastrointestinal stromal tumor, NOS, in situ (C26.9)",preferred
8936,3,Gastrointestinal stromal sarcoma (C26.9),preferred
8936,3,"Gastrointestinal stromal tumor, malignant",alternate
8936,3,"GIST, malignant",alternate
8940,0,"Pleomorphic adenoma (C07._, C08._)",preferred
8940,0,"Mixed tumor, NOS",alternate
8940,0,"Mixed tumor, salivary gland type, NOS",alternate
8940,0,Chondroid syringoma,alternate
8940,3,"Mixed tumor, malignant, NOS (C07._, C08._)",preferred
8940,3,"Mixed tumor, salivary gland type, malignant",alternate
8940,3,Malignant chondroid syringoma,alternate
8941,2,"Carcinoma in situ in pleomorphic adenoma (C07._, C08._)",preferred
8941,3,"Carcinoma in pleomorphic adenoma (C07._, C08._)",preferred
8950,3,Mullerian mixed tumor (C54._),preferred
8951,3,Mesodermal mixed tumor (C22.0),preferred
8959,0,Benign cystic nephroma (C64._),preferred
8959,1,Cystic partially differentiated nephroblastoma (C64._),preferred
8959,3,Malignant cystic nephroma (C64._),preferred
8959,3,Malignant multilocular cystic nephroma,alternate
8960,1,Mesoblastic nephroma (C64._),preferred
8960,3,"Nephroblastoma, NOS (C64._)",preferred
8960,3,Wilms tumor,alternate
8960,3,"Nephroma, NOS",alternate
8963,3,Malignant rhabdoid tumor,preferred
8963,3,Rhabdoid sarcoma,alternate
8963,3,"Rhabdoid tumor, NOS",alternate
8964,3,Clear cell sarcoma of kidney (C64._),preferred
8965,0,Nephrogenic adenofibroma (C64._),preferred
8966,0,Renomedullary interstitial cell tumor (C64._),preferred
8966,0,Renomedullary fibroma,alternate
8967,0,Ossifying renal tumor (C64._),preferred
8970,3,Hepatoblastoma (C22.0),preferred
8970,3,Embryonal hepatoma,alternate
8970,3,"Hepatoblastoma, epithelioid (C22.0)",alternate
8970,3,"Hepatoblastoma, mixed epithelial-mesenchymal (C22.0)",alternate
8971,3,Pancreastoblastoma (C25._),preferred
8972,3,Pulmonary blastoma (C34._),preferred
8972,3,Pneumoblastoma,alternate
8973,3,Pleuropulmonary blastoma (C34._),preferred
8974,1,Sialoblastoma,preferred
8975,1,Calcifying nested epithelial stromal tumor (C22.0),preferred
8980,3,"Carcinosarcoma, NOS",preferred
8981,3,"Carcinosarcoma, embryonal",preferred
8982,0,Myoepithelioma,preferred
8982,0,Myoepithelial tumor,alternate
8982,0,Myoepithelial adenoma,alternate
8982,3,Malignant myoepithelioma,preferred
8982,3,Myoepithelial carcinoma,alternate
8983,0,Adenomyoepithelioma (C50._),preferred
8983,3,Adenomyoepithelioma with carcinoma (C50._),preferred
8990,0,"Mesenchymoma, benign (C49._)",preferred
8990,1,"Mesenchymoma, NOS (C49._)",preferred
8990,1,Mixed mesenchymal tumor,alternate
8990,3,"Mesenchymoma, malignant (C49._)",preferred
8990,3,Mixed mesenchymal sarcoma,alternate
8990,3,"Phosphaturic mesenchymal tumor, malignant",alternate
8991,3,Embryonal sarcoma (C49._),preferred
9000,0,"Brenner tumor, NOS (C56.9)",preferred
9000,1,"Brenner tumor, borderline malignancy (C56.9)",preferred
9000,1,"Brenner tumor, proliferating",alternate
9000,3,"Brenner tumor, malignant (C56.9)",preferred
9010,0,"Fibroadenoma, NOS (C50._)",preferred
9011,0,Intracanalicular fibroadenoma (C50._),preferred
9012,0,Pericanalicular fibroadenoma (C50._),preferred
9013,0,"Adenofibroma, NOS (C56.9)",preferred
9013,0,"Cystadenofibroma, NOS",alternate
9013,0,Papillary adenofibroma,alternate
9013,3,"Adenofibroma, malignant (C56.9)",preferred
9014,0,"Serous adenofibroma, NOS (C56.9)",preferred
9014,0,"Serous cystadenofibroma, NOS",alternate
9014,1,Serous adenofibroma of borderline malignancy (C56.9),preferred
9014,1,Serous cystadenofibroma of borderline malignancy,alternate
9014,2,"Serous adenocarcinofibroma, in situ (C56.9)",preferred
9014,3,Serous adenocarcinofibroma (C56.9),preferred
9014,3,Malignant serous adenofibroma,alternate
9014,3,Serous cystadenocarcinofibroma,alternate
9014,3,Malignant serous cystadenofibroma,alternate
9015,0,"Mucinous adenofibroma, NOS (C56.9)",preferred
9015,0,"Mucinous cystadenofibroma, NOS",alternate
9015,1,Mucinous adenofibroma of borderline malignancy (C56.9),preferred
9015,1,Mucinous cystadenofibroma of borderline malignancy,alternate
9015,3,Mucinous adenocarcinofibroma (C56.9),preferred
9015,3,Malignant mucinous adenofibroma,alternate
9015,3,Mucinous cystadenocarcinofibroma,alternate
9015,3,Malignant mucinous cystadenofibroma,alternate
9016,0,Giant fibroadenoma (C50._),preferred
9020,0,"Phyllodes tumor, benign (C50._)",preferred
9020,0,"Cystosarcoma phyllodes, benign",alternate
9020,1,"Phyllodes tumor, borderline (C50._)",preferred
9020,1,"Cystosarcoma phyllodes, NOS",alternate
9020,1,"Phyllodes tumor, NOS",alternate
9020,3,"Phyllodes tumor, malignant (C50._)",preferred
9020,3,"Cystosarcoma phyllodes, malignant",alternate
9020,3,"Periductal stromal tumor, low grade (C50._)",alternate
9030,0,Juvenile fibroadenoma (C50._),preferred
9040,0,"Synovioma, benign (C49._)",preferred
9040,3,"Synovial sarcoma, NOS (C49._)",preferred
9040,3,"Synovioma, NOS",alternate
9040,3,"Synovioma, malignant",alternate
9041,3,"Synovial sarcoma, spindle cell (C49._)",preferred
9041,3,"Synovial sarcoma, monophasic fibrous",alternate
9042,3,"Synovial sarcoma, epithelioid cell (C49._)",preferred
9043,3,"Synovial sarcoma, biphasic (C49._)",preferred
9044,3,"Clear cell sarcoma, NOS (C49._)",preferred
9044,3,"Clear cell sarcoma, of tendons and aponeuroses",alternate
9044,3,"Melanoma, malignant, of soft parts",alternate
9045,3,"Biphenotypic sinonasal sarcoma (C30.0, C31.0-C31.3, C31.8, C31.9)",preferred
9050,0,"Mesothelioma, benign",preferred
9050,3,"Mesothelioma, malignant",preferred
9050,3,"Mesothelioma, NOS",alternate
9051,0,"Fibrous mesothelioma, benign",preferred
9051,3,"Fibrous mesothelioma, malignant",preferred
9051,3,Spindled mesothelioma,alternate
9051,3,Sarcomatoid mesothelioma,alternate
9051,3,Desmoplastic mesothelioma,alternate
9051,3,"Fibrous mesothelioma, NOS",alternate
9052,0,"Epithelioid mesothelioma, benign",preferred
9052,0,"Well differentiated papillary mesothelioma, benign",alternate
9052,0,Mesothelial papilloma,alternate
9052,3,"Epithelioid mesothelioma, malignant",preferred
9052,3,"Epithelioid mesothelioma, NOS",alternate
9053,3,"Mesothelioma, biphasic, malignant",preferred
9053,3,"Mesothelioma, biphasic, NOS",alternate
9054,0,"Adenomatoid tumor, NOS",preferred
9054,3,"Adenomatoid tumor, malignant",preferred
9055,0,"Multicystic mesothelioma, benign (C48._)",preferred
9055,0,"Cystic mesothelioma, benign",alternate
9055,1,"Cystic mesothelioma, NOS (C48._)",preferred
9055,3,"Multicystic mesothelioma, malignant (C48._)",preferred
9060,2,"Dysgerminoma, in situ (C56.9 [F], C62._[M])",preferred
9060,3,"Dysgerminoma (C56.9 [F], C62._[M])",preferred
9061,2,"Seminoma, in situ (C62._)",preferred
9061,3,"Seminoma, NOS (C62._)",preferred
9062,3,"Seminoma, anaplastic (C62._)",preferred
9062,3,Seminoma with high mitotic index,alternate
9063,2,"Spermatocytic seminoma, in situ (C62._)",preferred
9063,3,Spermatocytic seminoma (C62._),preferred
9063,3,Spermatocytoma,alternate
9064,2,Intratubular malignant germ cells (C62._),preferred
9064,2,Intratubular germ cell neoplasia,alternate
9064,3,Germinoma (C62._),preferred
9064,3,"Germ cell tumor, NOS",alternate
9065,3,"Germ cell tumor, nonseminomatous (C62._)",preferred
9070,2,"Embryonal carcinoma, NOS, in situ",preferred
9070,3,"Embryonal carcinoma, NOS",preferred
9070,3,Embryonal adenocarcinoma,alternate
9071,3,"Yolk sac tumor (C56.9 [F], C62._[M])",preferred
9071,3,"Embryonal carcinoma, infantile",alternate
9071,3,Hepatoid yolk sac tumor,alternate
9071,3,Endodermal sinus tumor,alternate
9071,3,Polyvesicular vitelline tumor,alternate
9071,3,Orchioblastoma,alternate
9072,3,Polyembryoma,preferred
9072,3,"Embryonal carcinoma, polyembryonal type",alternate
9073,1,"Gonadoblastoma (C56.9 [F], C62._[M])",preferred
9073,1,Gonocytoma,alternate
9073,3,"Gonadoblastoma, malignant (C56.9 [F], C62._[M])",preferred
9080,0,"Teratoma, benign",preferred
9080,0,Adult cystic teratoma,alternate
9080,0,"Adult teratoma, NOS",alternate
9080,0,"Cystic teratoma, NOS",alternate
9080,0,"Teratoma, differentiated",alternate
9080,0,Mature teratoma,alternate
9080,1,"Teratoma, NOS",preferred
9080,1,Solid teratoma,alternate
9080,2,"Teratoma, in situ",preferred
9080,3,"Teratoma, malignant, NOS",preferred
9080,3,Embryonal teratoma,alternate
9080,3,"Teratoblastoma, malignant",alternate
9080,3,"Immature teratoma, malignant",alternate
9080,3,"Immature teratoma, NOS",alternate
9081,2,"Teratocarcinoma, in situ (C22.0)",preferred
9081,3,Teratocarcinoma (C22.0),preferred
9081,3,Mixed embryonal carcinoma and teratoma,alternate
9082,3,"Malignant teratoma, undifferentiated",preferred
9082,3,"Malignant teratoma, anaplastic",alternate
9083,3,"Malignant teratoma, intermediate",preferred
9084,0,"Dermoid cyst, NOS",preferred
9084,0,"Dermoid, NOS",alternate
9084,2,"Dermoid cyst, in situ, NOS",preferred
9084,3,Teratoma with malignant transformation,preferred
9084,3,Dermoid cyst with malignant transformation,alternate
9084,3,Dermoid cyst with secondary tumor,alternate
9085,2,"Mixed germ cell tumor, in situ",preferred
9085,3,Mixed germ cell tumor,preferred
9085,3,Mixed teratoma and seminoma,alternate
9086,3,Germ cell tumors with associated hematological malignancy (C37.9),preferred
9090,0,"Struma ovarii, NOS (C56.9)",preferred
9090,3,"Struma ovarii, malignant (C56.9)",preferred
9091,1,Strumal carcinoid (C56.9),preferred
9091,1,Struma ovarii and carcinoid,alternate
9091,3,"Strumal carcinoid, malignant (C56.9)",preferred
9100,0,"Hydatidiform mole, NOS (C58.9)",preferred
9100,0,Hydatid mole,alternate
9100,0,Complete hydatidiform mole,alternate
9100,1,Invasive hydatidiform mole (C58.9),preferred
9100,1,Chorioadenoma destruens,alternate
9100,1,Chorioadenoma,alternate
9100,1,"Invasive mole, NOS",alternate
9100,1,Malignant hydatidiform mole,alternate
9100,2,"Choriocarcinoma in situ, NOS (C58.9)",preferred
9100,3,"Choriocarcinoma, NOS (C58.9)",preferred
9100,3,Chorionepithelioma,alternate
9100,3,Chorioepithelioma,alternate
9101,2,"Choriocarcinoma combined with other germ cell elements, in situ",preferred
9101,3,Choriocarcinoma combined with other germ cell elements,preferred
9101,3,Choriocarcinoma combined with teratoma,alternate
9101,3,Choriocarcinoma combined with embryonal carcinoma,alternate
9102,3,"Malignant teratoma, trophoblastic (C62._)",preferred
9103,0,Partial hydatidiform mole (C58.9),preferred
9103,3,"Partial hydatidiform mole, malignant (C58.9)",preferred
9104,1,Placental site trophoblastic tumor (C58.9),preferred
9104,3,Malignant placental site trophoblastic tumor (C58.9),preferred
9105,3,"Trophoblastic tumor, epithelioid",preferred
9110,0,"Mesonephroma, benign",preferred
9110,0,Wolffian duct adenoma,alternate
9110,0,Mesonephric adenoma,alternate
9110,1,"Mesonephric tumor, NOS",preferred
9110,1,Wolffian duct tumor,alternate
9110,3,"Mesonephroma, malignant",preferred
9110,3,Mesonephric adenocarcinoma,alternate
9110,3,"Mesonephroma, NOS",alternate
9110,3,Wolffian duct carcinoma,alternate
9110,3,Adenocarcinoma of rete ovarii (C56.9),alternate
9120,0,"Hemangioma, NOS",preferred
9120,0,"Angioma, NOS",alternate
9120,0,Chorioangioma,alternate
9120,3,Hemangiosarcoma (C49._),preferred
9120,3,Angiosarcoma,alternate
9121,0,Cavernous hemangioma,preferred
9121,1,"Cavernous hemangioma, borderline",preferred
9122,0,Venous hemangioma,preferred
9123,0,Racemose hemangioma,preferred
9123,0,Arteriovenous hemangioma,alternate
9124,3,Kupffer cell sarcoma (C22.0),preferred
9125,0,Epithelioid hemangioma,preferred
9125,0,Histiocytoid hemangioma,alternate
9125,3,"Epithelioid hemangioma, malignant (C49._)",preferred
9130,0,"Hemangioendothelioma, benign",preferred
9130,1,"Hemangioendothelioma, NOS",preferred
9130,1,Angioendothelioma,alternate
9130,1,Kaposiform hemangioendothelioma,alternate
9130,3,"Hemangioendothelioma, malignant (C49._)",preferred
9130,3,Hemangioendothelial sarcoma,alternate
9131,0,Capillary hemangioma,preferred
9131,0,Juvenile hemangioma,alternate
9131,0,Hemangioma simplex,alternate
9131,0,Infantile hemangioma,alternate
9131,0,Plexiform hemangioma,alternate
9132,0,Intramuscular hemangioma,preferred
9133,1,"Epithelioid hemangioendothelioma, NOS",preferred
9133,3,Epithelioid hemangioendothelioma,preferred
9133,3,Intravascular bronchial alveolar tumor,alternate
9135,1,Endovascular papillary angioendothelioma,preferred
9135,1,Dabska tumor,alternate
9136,1,Spindle cell hemangioendothelioma,preferred
9136,1,Spindle cell angioendothelioma,alternate
9137,3,Intimal sarcoma,preferred
9137,3,Pulmonary artery intimal sarcoma,alternate
9140,3,Kaposi Sarcoma,preferred
9140,3,Multiple hemorrhagic sarcoma,alternate
9141,0,Angiokeratoma,preferred
9142,0,Verrucous keratotic hemangioma,preferred
9150,0,"Hemangiopericytoma, benign",preferred
9150,1,"Hemangiopericytoma, NOS (C49._)",preferred
9150,1,Hemangiopericytic meningioma,alternate
9150,3,"Hemangiopericytoma, malignant (C49._)",preferred
9160,0,"Angiofibroma, NOS",preferred
9160,0,Juvenile angiofibroma,alternate
9160,0,Fibrous papule of nose,alternate
9160,0,Involuting nevus,alternate
9160,0,Giant cell angiofibroma,alternate
9160,0,Cellular angiofibroma,alternate
9160,3,Angiofibrosarcoma (C49._),preferred
9161,0,Acquired tufted hemangioma,preferred
9161,1,Hemangioblastoma (C49._),preferred
9161,1,Angioblastoma,alternate
9161,3,"Hemangioblastoma, malignant (C49._)",preferred
9170,0,"Lymphangioma, NOS",preferred
9170,0,"Lymphangioendothelioma, NOS",alternate
9170,3,Lymphangiosarcoma (C49._),preferred
9170,3,Lymphangioendothelial sarcoma,alternate
9170,3,"Lymphangioendothelioma, malignant",alternate
9171,0,Capillary lymphangioma,preferred
9172,0,Cavernous lymphangioma,preferred
9173,0,Cystic lymphangioma,preferred
9173,0,Cystic hygroma,alternate
9173,0,"Hygroma, NOS",alternate
9174,0,Lymphangiomyoma,preferred
9174,1,Lymphangiomyomatosis (C49._),preferred
9174,1,Lymphangioleiomyomatosis,alternate
9175,0,Hemolymphangioma,preferred
9180,0,"Osteoma, NOS (C40._, C41._)",preferred
9180,3,"Osteosarcoma, NOS (C40._, C41._)",preferred
9180,3,"Osteogenic sarcoma, NOS",alternate
9180,3,Osteochondrosarcoma,alternate
9180,3,Osteoblastic sarcoma,alternate
9181,3,"Chondroblastic osteosarcoma (C40._, C41._)",preferred
9182,3,"Fibroblastic osteosarcoma (C40._, C41._)",preferred
9182,3,Osteofibrosarcoma,alternate
9183,3,"Telangiectatic osteosarcoma (C40._, C41._)",preferred
9184,3,"Osteosarcoma in Paget disease of bone (C40._, C41._)",preferred
9185,3,"Small cell osteosarcoma (C40._, C41._)",preferred
9185,3,Round cell osteosarcoma,alternate
9186,3,"Central osteosarcoma (C40._, C41._)",preferred
9186,3,Conventional central osteosarcoma,alternate
9186,3,Medullary osteosarcoma,alternate
9187,3,"Intraosseous well differentiated osteosarcoma (C40._, C41._)",preferred
9187,3,"Low-grade central osteosarcoma (C40._, C41._)",alternate
9187,3,"Low-grade intramedullary osteosarcoma (C40._, C41._)",alternate
9187,3,Intraosseous low grade osteosarcoma,alternate
9191,0,"Osteoid osteoma (C40._, C41._)",preferred
9192,3,"Parosteal osteosarcoma (C40._, C41._)",preferred
9192,3,Juxtacortical osteosarcoma,alternate
9193,3,"Periosteal osteosarcoma (C40._, C41._)",preferred
9194,3,"High grade surface osteosarcoma (C40._, C41._)",preferred
9195,3,"Intracortical osteosarcoma (C40._, C41._)",preferred
9200,0,"Osteoblastoma, NOS (C40._, C41._)",preferred
9200,0,Giant osteoid osteoma,alternate
9200,1,"Aggressive osteoblastoma (C40._, C41._)",preferred
9200,3,"Osteosarcoma, malignant (C40._, C41._)",preferred
9210,0,"Osteochondroma (C40._, C41._)",preferred
9210,0,Cartilaginous exostosis,alternate
9210,0,Osteocartilaginous exostosis,alternate
9210,0,Ecchondroma,alternate
9210,1,"Osteochondromatosis, NOS (C40._, C41._)",preferred
9210,1,Ecchondrosis,alternate
9220,0,"Chondroma, NOS (C40._, C41.)",preferred
9220,0,Enchondroma,alternate
9220,1,"Chondromatosis, NOS (C40._, C41._)",preferred
9220,3,"Chondrosarcoma, NOS (C40._, C41._)",preferred
9220,3,Fibrochondrosarcoma,alternate
9220,3,Chondrosarcoma grade 2/3,alternate
9221,0,"Juxtacortical chondroma (C40._, C41._)",preferred
9221,0,Periosteal chondroma,alternate
9221,3,"Juxtacortical chondrosarcoma (C40._, C41._)",preferred
9221,3,Periosteal chondrosarcoma,alternate
9230,0,"Chondroblastoma, NOS (C40._, C41._)",preferred
9230,0,Chondromatous giant cell tumor,alternate
9230,0,Codman tumor,alternate
9230,3,"Chondroblastoma, malignant (C40._, C41._)",preferred
9231,3,"Myxoid chondrosarcoma (C40._, C41._)",preferred
9240,3,Mesenchymal chondrosarcoma (C49._),preferred
9241,0,"Chondromyxoid fibroma (C40._, C41._)",preferred
9242,3,"Clear cell chondrosarcoma (C40._, C41._)",preferred
9243,3,"Dedifferentiated chondrosarcoma (C40._, C41._)",preferred
9250,1,"Giant cell tumor of bone, NOS (C40._, C41._)",preferred
9250,1,"Osteoclastoma, NOS",alternate
9250,3,"Giant cell tumor of bone, malignant (C40._, C41._)",preferred
9250,3,"Osteoclastoma, malignant",alternate
9250,3,Giant cell sarcoma of bone,alternate
9251,1,"Giant cell tumor of soft parts, NOS (C49._)",preferred
9251,3,Malignant giant cell tumor of soft parts (C49._),preferred
9252,0,Tenosynovial giant cell tumor (C49._),preferred
9252,0,Fibrous histiocytoma of tendon sheath,alternate
9252,0,Giant cell tumor of tendon sheath,alternate
9252,3,Malignant tenosynovial giant cell tumor (C49._),preferred
9252,3,"Giant cell tumor of tendon sheath, malignant",alternate
9260,3,"Ewing sarcoma (C40._, C41._)",preferred
9260,3,Ewing tumor,alternate
9261,3,"Adamantinoma of long bones (C40._, C41._)",preferred
9261,3,Tibial adamantinoma,alternate
9262,0,"Ossifying fibroma (C40._, C41._)",preferred
9262,0,Fibro-osteoma,alternate
9262,0,Osteofibroma,alternate
9270,0,"Odontogenic tumor, benign (C41._)",preferred
9270,1,"Odontogenic tumor, NOS (C41._)",preferred
9270,3,"Odontogenic tumor, malignant (C41._)",preferred
9270,3,Odontogenic carcinoma,alternate
9270,3,Odontogenic sarcoma,alternate
9270,3,Primary intraosseous carcinoma,alternate
9270,3,Ameloblastic carcinoma,alternate
9271,0,Ameloblastic fibrodentinoma (C41._),preferred
9271,0,Dentinoma,alternate
9272,0,"Cementoma, NOS (C41._)",preferred
9272,0,Periapical cemental dysplasia,alternate
9272,0,Periapical cemento-osseous dysplasia,alternate
9273,0,"Cementoblastoma, benign (C41._)",preferred
9274,0,Cementifying fibroma (C41._),preferred
9274,0,Cemento-ossifying fibroma,alternate
9275,0,Gigantiform cementoma (C41._),preferred
9275,0,Florid osseous dysplasia,alternate
9280,0,"Odontoma, NOS (C41._)",preferred
9281,0,Compound odontoma (C41._),preferred
9282,0,Complex odontoma (C41._),preferred
9282,3,"Complex odontoma, malignant (C41._)",preferred
9290,0,Ameloblastic fibro-odontoma (C41._),preferred
9290,0,Fibroameloblastic odontoma,alternate
9290,3,Ameloblastic odontosarcoma (C41._),preferred
9290,3,Ameloblastic fibrodentinosarcoma,alternate
9290,3,Ameloblastic fibro-odontosarcoma,alternate
9300,0,Adenomatoid odontogenic tumor (C41._),preferred
9300,0,Adenoameloblastoma,alternate
9301,0,Calcifying odontogenic cyst (C41._),preferred
9302,0,Odontogenic ghost cell tumor (C41._),preferred
9302,3,"Ghost cell odontogenic carcinoma (C41.0, C41.1)",preferred
9310,0,"Ameloblastoma, NOS (C41._)",preferred
9310,0,"Adamantinoma, NOS",alternate
9310,3,"Ameloblastoma, malignant (C41._)",preferred
9310,3,"Adamantinoma, malignant",alternate
9311,0,Odontoameloblastoma (C41._),preferred
9312,0,Squamous odontogenic tumor (C41._),preferred
9312,3,"Squamous odontogenic tumor, malignant (C41._)",preferred
9320,0,Odontogenic myxoma (C41._),preferred
9320,0,Odontogenic myxofibroma,alternate
9321,0,Central odontogenic fibroma (C41._),preferred
9321,0,"Odontogenic fibroma, NOS",alternate
9321,3,Central odontogenic fibrosarcoma (C41._),preferred
9322,0,Peripheral odontogenic fibroma (C41._),preferred
9330,0,Ameloblastic fibroma (C41._),preferred
9330,3,Ameloblastic fibrosarcoma (C41._),preferred
9330,3,Ameloblastic sarcoma,alternate
9330,3,Odontogenic fibrosarcoma,alternate
9340,0,Calcifying epithelial odontogenic tumor (C41._),preferred
9340,0,Pindborg tumor,alternate
9341,1,Clear cell odontogenic tumor (C41._),preferred
9341,3,"Clear cell odontogenic carcinoma (C41.0, C41.1)",preferred
9342,3,Odontogenic carcinosarcoma (C41._),preferred
9350,0,"Craniopharyngioma, benign (C75.2)",preferred
9350,1,Craniopharyngioma (C75.2),preferred
9350,1,Rathke pouch tumor,alternate
9350,3,"Craniopharyngioma, malignant (C75.2)",preferred
9351,0,"Craniopharyngioma, adamantinomatous, benign (C75.2)",preferred
9351,1,Adamantinomatous craniopharyngioma (C75.2),preferred
9351,3,"Malignant craniopharyngioma, adamantinomatous (C75.2)",preferred
9352,0,"Papillary craniopharyngioma, benign (C75.2)",preferred
9352,1,Papillary craniopharyngioma (C75.2),preferred
9360,0,"Pinealoma, benign (C75.3)",preferred
9360,1,"Pinealoma, NOS (C75.3)",preferred
9360,3,"Pinealoma, malignant (C75.3)",preferred
9361,1,Pineocytoma (C75.3),preferred
9361,3,"Pineocytoma, malignant (C75.3)",preferred
9362,3,Pineoblastoma (C75.3),preferred
9362,3,Mixed pineal tumor,alternate
9362,3,Mixed pineocytoma-pineoblastoma,alternate
9362,3,Pineal parenchymal tumor of intermediate differentiation,alternate
9362,3,Transitional pineal tumor,alternate
9363,0,"Melanotic neuroectodermal tumor (C40._, C41._)",preferred
9363,0,Retinal anlage tumor,alternate
9363,0,Melanoameloblastoma,alternate
9363,0,Melanotic progonoma,alternate
9363,3,"Melanotic neuroectodermal tumor, malignant (C40._, C41._)",preferred
9364,3,Peripheral neuroectodermal tumor,preferred
9364,3,"Neuroectodermal tumor, NOS",alternate
9364,3,"Peripheral primitive neuroectodermal tumor, NOS",alternate
9364,3,PPNET,alternate
9365,3,Askin tumor,preferred
9370,3,"Chordoma, NOS",preferred
9371,3,Chondroid chordoma,preferred
9372,3,Dedifferentiated chordoma,preferred
9373,0,Parachordoma,preferred
9380,0,"Glioma, benign (C71._)",preferred
9380,1,"Glioma, borderline (C71._)",preferred
9380,3,"Glioma, malignant (C71._)",preferred
9380,3,"Glioma, NOS",alternate
9381,0,"Gliomatosis cerebri, benign (C71._)",preferred
9381,3,Gliomatosis cerebri (C71._),preferred
9382,0,"Mixed glioma, benign (C71._)",preferred
9382,3,Mixed glioma (C71._),preferred
9382,3,Oligoastrocytoma,alternate
9382,3,Anaplastic oligoastrocytoma (C71._),alternate
9382,3,Anaplastic oligoastrocytoma,alternate
9382,3,"Oligoastrocytoma, NOS (C71._)",alternate
9383,1,Subependymoma (C71._),preferred
9383,1,Subependymal glioma,alternate
9383,1,"Subependymal astrocytoma, NOS",alternate
9383,1,Mixed subependymoma-ependymoma,alternate
9383,3,"Subependymoma, malignant (C71._)",preferred
9384,1,Supependymal giant cell astrocytoma (C71._),preferred
9384,3,"Supependymal giant cell astrocytoma, malignant (C71._)",preferred
9385,3,"Diffuse midline glioma, H3 K27M-mutant (C71._)",preferred
9390,0,"Choroid plexus papilloma, NOS (C71.5)",preferred
9390,1,Atypical choroid plexus papilloma (C71.5),preferred
9390,3,"Choroid plexus papilloma, malignant (C71.5)",preferred
9390,3,"Choroid plexus papilloma, anaplastic",alternate
9390,3,"Choroid plexus papilloma, malignant",alternate
9391,3,"Ependymoma, NOS (C71._)",preferred
9391,3,Clear cell ependymoma,alternate
9391,3,Epithelial ependymoma,alternate
9391,3,Tanycytic ependymoma,alternate
9391,3,Cellular ependymoma,alternate
9392,3,"Ependymoma, anaplastic (C71._)",preferred
9392,3,Ependymoblastoma,alternate
9393,0,"Papillary ependymoma, benign (C71._)",preferred
9393,3,"Papillary ependymoma, NOS (C71._)",preferred
9394,1,Myxopapillary ependymoma (C71._),preferred
9394,3,"Myxopapillary ependymoma, malignant (C71._)",preferred
9395,3,Papillary tumor of pineal region (C75.3),preferred
9396,3,"Ependymoma, RELA fusion-positive (C71._)",preferred
9400,1,"Astrocytoma, borderline malignancy (C71._)",preferred
9400,3,"Astrocytoma, NOS (C71._)",preferred
9400,3,"Astrocytoma, low grade",alternate
9400,3,"Diffuse astrocytoma, low grade",alternate
9400,3,Cystic astrocytoma,alternate
9400,3,"Diffuse astrocytoma, IDH-mutant (C71._)",alternate
9400,3,"Diffuse astrocytoma, IDH-wildtype (C71._)",alternate
9400,3,Astrocytic glioma,alternate
9400,3,Astroglioma,alternate
9400,3,Diffuse astrocytoma,alternate
9401,0,"Astrocytoma, anaplastic, benign (C71._)",preferred
9401,3,"Astrocytoma, anaplastic (C71._)",preferred
9401,3,"Anaplastic astrocytoma, IDH-mutant (C71._)",alternate
9401,3,"Anaplastic astrocytoma, IDH-wildtype (C71._)",alternate
9410,3,Protoplasmic astrocytoma (C71._),preferred
9411,3,Gemistocytic astrocytoma (C71._),preferred
9411,3,Gemistocytoma,alternate
9412,1,Desmoplastic infantile astrocytoma (C71._),preferred
9412,1,Desmoplastic infantile ganglioglioma,alternate
9413,0,Dysembryoplastic neuroepithelial tumor,preferred
9413,1,"Dysembryoplastic neuroepithelial tumor, borderline",preferred
9413,3,"Dysembryoplastic neuroepithelial tumor, malignant",preferred
9420,3,Fibrillary astrocytoma (C71._),preferred
9420,3,Fibrous astrocytoma,alternate
9421,1,"Pilocytic astrocytoma, uncertain (C71._)",preferred
9421,1,Piloid astrocytoma,alternate
9421,1,Juvenile astrocytoma,alternate
9421,1,"Spongioblastoma, NOS",alternate
9421,3,"Pilocytic astrocytoma, malignant (C71._)",preferred
9423,3,Polar spongioblastoma (C71._),preferred
9423,3,Spongioblastoma polare,alternate
9423,3,Primitive polar spongioblastoma,alternate
9424,3,Pleomorphic xanthoastrocytoma (C71._),preferred
9424,3,Anaplastic pleomorphic xanthroastrocytoma (C71._),alternate
9425,3,Pilomyxoid astrocytoma (C71._),preferred
9430,3,Astroblastoma (C71._),preferred
9431,1,Angiocentric glioma (C71._),preferred
9432,1,Pituicytoma (C75.1),preferred
9440,0,"Glioblastoma, benign (C71._)",preferred
9440,1,"Glioblastoma, borderline (C71._)",preferred
9440,3,"Glioblastoma, NOS (C71._)",preferred
9440,3,Glioblastoma multiforme,alternate
9440,3,Epithelioid glioblastoma (C71._),alternate
9440,3,Spongioblastoma multiforme,alternate
9440,3,"Glioblastoma, IDH wildtype (C71._)",alternate
9441,3,Giant cell glioblastoma (C71._),preferred
9441,3,Monstrocellular sarcoma,alternate
9442,1,Gliofibroma (C71._),preferred
9442,3,Gliosarcoma (C71._),preferred
9442,3,Glioblastoma with sarcomatous component,alternate
9444,1,Chordoid glioma (C71._),preferred
9444,1,Chordoid glioma of third ventricle,alternate
9445,3,"Glioblastoma, IDH-mutant (C71._)",preferred
9450,0,"Oligodendroglioma, benign (C71._)",preferred
9450,3,"Oligodendroglioma, NOS (C71._)",preferred
9450,3,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted (C71._)",alternate
9451,3,"Oligodendroglioma, anaplastic (C71._)",preferred
9451,3,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q codeleted (C71._)",alternate
9460,3,Oligodendroblastoma (C71._),preferred
9470,3,"Medulloblastoma, NOS (C71.6)",preferred
9470,3,Melanotic medulloblastoma,alternate
9470,3,"Medulloblastoma, classic (C71._)",alternate
9471,3,Desmoplastic nodular medulloblastoma (C71.6),preferred
9471,3,"Medulloblastoma, SHH-activated and TP53-wildtype (C71._)",alternate
9471,3,Desmoplastic medulloblastoma,alternate
9471,3,Circumscribed arachnoidal cerebellar sarcoma,alternate
9471,3,Medulloblastoma with extensive nodularity,alternate
9472,3,Medullomyoblastoma (C71.6),preferred
9473,3,Primitive neuroectodermal tumor (C71._),preferred
9473,3,"PNET, NOS",alternate
9473,3,"Central primitive neuroectodermal tumor, NOS",alternate
9473,3,CPNET,alternate
9473,3,Supratentorial PNET,alternate
9474,3,Large cell medulloblastoma (C71.6),preferred
9474,3,Anaplastic medulloblastoma,alternate
9475,3,"Medulloblastoma, WNT-activated (C71._)",preferred
9476,3,"Medulloblastoma, SHH-activated and TP53 mutant (C71._)",preferred
9477,3,"Medulloblastoma, non-WNT/non-SHH (C71._)",preferred
9477,3,"Medulloblastoma, group 3 (C71._)",alternate
9477,3,"Medulloblastoma, group 4 (C71._)",alternate
9478,3,"Embryonal tumor with multilayered rosettes, NOS (C71._)",preferred
9478,3,Embryonal tumor with multilayered rosettes C19MC-altered (C71._),alternate
9480,3,"Cerebellar sarcoma, NOS (C71.6)",preferred
9490,0,Ganglioneuroma,preferred
9490,3,Ganglioneuroblastoma,preferred
9491,0,Ganglioneuromatosis,preferred
9492,0,Gangliocytoma,preferred
9493,0,Dysplastic gangliocytoma of cerebellum (C71.6),preferred
9500,0,"Neuroblastoma, benign (C71._)",preferred
9500,2,"Neuroblastoma, in situ",preferred
9500,3,"Neuroblastoma, NOS (C71._)",preferred
9500,3,Sympathicoblastoma,alternate
9500,3,Central neuroblastoma,alternate
9501,0,"Medulloepithelioma, benign (C69.4)",preferred
9501,0,"Diktyoma, benign",alternate
9501,3,"Medulloepithelioma, NOS (C69.4)",preferred
9501,3,"Diktyoma, malignant",alternate
9502,0,"Teratoid medulloepithelioma, benign (C69.4)",preferred
9502,3,Teratoid medulloepithelioma,preferred
9503,3,"Neuroepithelioma, NOS",preferred
9504,3,Spongioneuroblastoma,preferred
9505,0,"Ganglioglioma, benign",preferred
9505,1,"Ganglioglioma, NOS",preferred
9505,1,Glioneuroma,alternate
9505,1,Neuroastrocytoma,alternate
9505,3,"Ganglioglioma, anaplastic",preferred
9506,0,"Central neurocytoma, benign (C71.6)",preferred
9506,1,Central neurocytoma,preferred
9506,1,Neurolipocytoma,alternate
9506,1,Medullocytoma,alternate
9506,1,Extraventricular neurocytoma,alternate
9506,1,Neurocytoma,alternate
9506,1,Cerebellar liponeurocytoma,alternate
9506,1,Lipomatous medulloblastoma,alternate
9506,3,"Neurocytoma, malignant",preferred
9507,0,Pacinian tumor,preferred
9508,3,Atypical teratoid/rhabdoid tumor (C71._),preferred
9508,3,CNS Embryonal tumor with rhabdoid features (C71._),alternate
9508,3,Embryonal tumor with rhabdoid features (C71._),alternate
9509,1,Papillary glioneuronal tumor (C71._),preferred
9509,1,Diffuse leptomeningeal glioneuronal tumor (C71._),alternate
9509,1,Rosette-forming glioneuronal tumor (C71._),alternate
9510,0,Retinocytoma (C69.2),preferred
9510,3,"Retinoblastoma, NOS (C69.2)",preferred
9511,3,"Retinoblastoma, differentiated (C69.2)",preferred
9512,3,"Retinoblastoma, undifferentiated (C69.2)",preferred
9513,3,"Retinoblastoma, diffuse (C69.2)",preferred
9514,1,"Retinoblastoma, spontaneously regressed (C69.2)",preferred
9520,3,Olfactory neurogenic tumor (C30.0),preferred
9521,3,Olfactory neurocytoma (C30.0),preferred
9521,3,Esthesioneurocytoma,alternate
9522,3,Olfactory neuroblastoma (C30.0),preferred
9522,3,Esthesioneuroblastoma,alternate
9523,3,Olfactory neuroepithelioma (C30.0),preferred
9523,3,Esthesioneuroepithelioma,alternate
9530,0,"Meningioma, NOS (C70._)",preferred
9530,0,Microcystic meningioma,alternate
9530,0,Secretory meningioma,alternate
9530,0,Lymphoplasmacyte-rich meningioma,alternate
9530,0,Metaplastic meningioma,alternate
9530,1,"Meningiomatosis, NOS (C70._)",preferred
9530,1,Diffuse meningiomatosis,alternate
9530,1,Multiple meningiomas,alternate
9530,3,"Meningioma, malignant (C70._)",preferred
9530,3,"Meningioma, anaplastic",alternate
9530,3,Leptomeningeal sarcoma,alternate
9530,3,Meningeal sarcoma,alternate
9530,3,Meningothelial sarcoma,alternate
9531,0,Meningiothelial meningioma (C70._),preferred
9531,0,Syncytial meningioma,alternate
9531,0,Endotheliomatous meningioma,alternate
9531,1,"Meningiothelial meningioma, borderline (C70._)",preferred
9531,3,"Meningiothelial meningioma, malignant (C70._)",preferred
9532,0,Fibrous meningioma (C70._),preferred
9532,0,Fibroblastic meningioma,alternate
9532,3,"Fibrous meningioma, malignant (C70._)",preferred
9533,0,Psammomatous meningioma (C70._),preferred
9533,3,"Psammomatous meningioma, malignant (C70._)",preferred
9534,0,Angiomatous meningioma (C70._),preferred
9534,3,"Angiomatous meningioma, malignant (C70._)",preferred
9535,0,Hemangioblastic meningioma [OBS] (C70._),preferred
9535,0,Angioblastic meningioma,alternate
9535,3,"Hemangioblastic meningioma, malignant (C70._)",preferred
9537,0,Transitional meningioma (C70._),preferred
9537,0,Mixed meningioma,alternate
9537,3,"Transitional meningioma, malignant (C70._)",preferred
9538,0,"Clear cell meningioma, benign (C70._)",preferred
9538,1,Clear cell meningioma (C70._),preferred
9538,1,Chordoid meningioma,alternate
9538,3,Papillary meningioma (C70._),preferred
9538,3,Rhabdoid meningioma,alternate
9539,0,"Atypical meningioma, benign (C70._)",preferred
9539,1,"Atypical meningioma, uncertain (C70._)",preferred
9539,3,Meningeal sarcomatosis (C70._),preferred
9540,0,"Neurofibroma, NOS",preferred
9540,1,"Neurofibromatosis, NOS",preferred
9540,1,Multiple neurofibromatosis,alternate
9540,1,Von Recklinghausen disease,alternate
9540,1,Recklinghausen disease,alternate
9540,3,Malignant peripheral nerve sheath tumor,preferred
9540,3,Melanotic MPNST,alternate
9540,3,Melanotic psammomatous MPNST,alternate
9540,3,"MPNST, NOS",alternate
9540,3,Neurofibrosarcoma,alternate
9540,3,Neurogenic sarcoma,alternate
9540,3,Neurosarcoma,alternate
9540,3,MPNST with glandular differentiation,alternate
9540,3,Epithelioid MPNST,alternate
9540,3,MPNST with mesenchymal differentiation,alternate
9541,0,Melanotic neurofibroma,preferred
9542,3,"Epithelioid malignant peripheral nerve sheath tumor  (C47.0-C47.6, C47.8, C47.9)",preferred
9550,0,"Plexiform neurofibroma, NOS",preferred
9550,0,Plexiform neuroma,alternate
9550,1,"Plexiform neurofibroma, borderline malignant",preferred
9560,0,"Neurilemoma, NOS",preferred
9560,0,"Schwannoma, NOS",alternate
9560,0,Neurinoma,alternate
9560,0,Acoustic neuroma,alternate
9560,0,Pigmented schwannoma,alternate
9560,0,Melanotic schwannoma,alternate
9560,0,Plexiform schwannoma,alternate
9560,0,Cellular schwannoma,alternate
9560,0,Degenerated schwannoma,alternate
9560,0,Ancient schwannoma,alternate
9560,0,Psammomatous schwannoma,alternate
9560,1,"Melanotic schwannoma (C72.4, C72.5)",preferred
9560,1,Neurinomastosis,alternate
9560,3,"Neurilemoma, malignant [OBS]",preferred
9560,3,"Malignant schwannoma, NOS",alternate
9560,3,Neurilemosarcoma,alternate
9561,3,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,preferred
9561,3,"Triton tumor, malignant",alternate
9561,3,Malignant schwannoma with rhabdomyoblastic differentiation,alternate
9561,3,MPNST with rhabdomyoblastic differentiation,alternate
9562,0,Neurothekeoma,preferred
9562,0,Nerve sheath myxoma,alternate
9562,3,"Neurothekeoma, malignant",preferred
9570,0,"Neuroma, NOS",preferred
9571,0,"Perineurioma, benign, NOS",preferred
9571,0,Intraneural perineurioma,alternate
9571,0,Soft tissue perineurioma,alternate
9571,1,"Perineurioma, borderline malignant",preferred
9571,3,"Perineurioma, malignant",preferred
9571,3,Perineural MPNST,alternate
9580,0,"Granular cell tumor, NOS (C49._)",preferred
9580,0,"Granular cell myoblastoma, NOS",alternate
9580,3,"Granular cell tumor, malignant (C49._)",preferred
9580,3,"Granular cell myoblastoma, malignant",alternate
9581,3,Alveolar soft part sarcoma (C49._),preferred
9582,0,Granular cell tumor of the sellar region (C49._),preferred
9590,3,"Malignant lymphoma, NOS",preferred
9590,3,"Lymphoma, NOS",alternate
9590,3,Microglioma,alternate
9591,3,"Non-Hodgkin lymphoma, NOS",preferred
9591,3,Hairy cell leukemia variant (HCL-v),alternate
9591,3,"Non-Hodgkin lymphoma, NOS",alternate
9591,3,"B cell lymphoma, NOS",alternate
9591,3,"Malignant lymphoma, non-cleaved cell, NOS",alternate
9591,3,"Malignant lymphoma, diffuse, NOS",alternate
9591,3,"Malignant lymphoma, lymphocytic, intermediate differentiation, nodular",alternate
9591,3,"Malignant lymphoma, small cell, noncleaved, diffuse",alternate
9591,3,"Malignant lymphoma, undifferentiated cell, non-Burkitt",alternate
9591,3,"Malignant lymphoma, undifferentiated cell type, NOS",alternate
9591,3,"Lymphosarcoma, NOS",alternate
9591,3,"Lymphosarcoma, diffuse",alternate
9591,3,"Reticulum cell sarcoma, NOS",alternate
9591,3,"Reticulum cell sarcoma, diffuse",alternate
9591,3,"Reticulosarcoma, NOS",alternate
9591,3,"Reticulosarcoma, diffuse",alternate
9591,3,"Malignant lymphoma, small cleaved cell, diffuse",alternate
9591,3,"Malignant lymphoma, lymphocytic, poorly differentiated, diffuse",alternate
9591,3,"Malignant lymphoma, small cleaved cell, NOS",alternate
9591,3,"Malignant lymphoma, cleaved cell, NOS",alternate
9596,3,"B-cell lymphoma, between diffuse large B and HL (composite HL and NHL) (C77._)",preferred
9597,3,Primary cutaneous follicle centre lymphoma (ICD-O-3 update),preferred
9650,3,Classical Hodgkin lymphoma (ICD-O-3 update) (C77._),preferred
9650,3,"Hodgkin disease, NOS",alternate
9650,3,"Malignant lymphoma, Hodgkin",alternate
9651,3,Lymphocyte-rich classical Hodgkin lymphoma (ICD-O-3 update) (C77._),preferred
9651,3,"Hodgkin disease, lymphocytic-histiocytic predominance",alternate
9651,3,"Hodgkin disease, lymphocyte predominance, diffuse",alternate
9651,3,"Classical Hodgkin lymphoma, lymphocyte- rich",alternate
9651,3,"Hodgkin disease, lymphocyte predominance, NOS",alternate
9652,3,Mixed cellularity classical Hodgkin lymphoma (ICD-O-3 update) (C77._),preferred
9652,3,"Classical Hodgkin lymphoma, mixed cellularity, NOS",alternate
9653,3,Lymphocyte-depleted classical Hodgkin lymphoma (ICD-O-3 update) (C77._),preferred
9653,3,"Classical Hodgkin lymphoma, lymphocyte depletion, NOS",alternate
9654,3,"Hodgkin lymphoma, lymphocytic depletion, diffuse fibrosis [OBS], see 9653/3 (ICD-O-3 update) (C77._)",preferred
9654,3,"Classical Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis",alternate
9655,3,"Hodgkin lymphoma, lymphocyte depletion, reticular (C77._)",preferred
9655,3,"Classical Hodgkin lymphoma, lymphocyte depletion, reticular",alternate
9659,3,Nodular lymphocyte predominant Hodgkin lymphoma (ICD-O-3 update) (C77._),preferred
9659,3,"Hodgkin lymphoma, lymphocyte predominance, nodular",alternate
9659,3,"Hodgkin paragranuloma, NOS",alternate
9659,3,"Hodgkin paragranuloma, nodular",alternate
9661,3,Hodgkin granuloma [OBS] (C77._),preferred
9662,3,Hodgkin sarcoma [OBS] (C77._),preferred
9663,3,Nodular sclerosis classical Hodgkin lymphoma (C77._),preferred
9663,3,"Classical Hodgkin lymphoma, nodular sclerosis, NOS",alternate
9663,3,"Hodgkin disease, nodular sclerosis, NOS",alternate
9664,3,"Hodgkin lymphoma, nodular sclerosis, cellular phase [OBS], see 9663/3 (ICD-O-3 update) (C77._)",preferred
9664,3,"Classical Hodgkin lymphoma, nodular sclerosis, cellular phase",alternate
9665,3,"Hodgkin lymphoma, nodular sclerosis, grade 1 [OBS], see 9663/3 (ICD-O-3 update) (C77._)",preferred
9665,3,"Classical Hodgkin lymphoma, nodular sclerosis, grade 1",alternate
9665,3,"Hodgkin disease, nodular sclerosis, lymphocyte predominance",alternate
9665,3,"Hodgkin disease, nodular sclerosis, mixed cellularity",alternate
9667,3,"Hodgkin lymphoma, nodular sclerosis, grade 2 [OBS], see 9663/3 (ICD-O-3 update) (C77._)",preferred
9667,3,"Hodgkin disease, nodular sclerosis, lymphocyte depletion",alternate
9667,3,"Hodgkin disease, nodular sclerosis, syncytial variant",alternate
9667,3,"Classical Hodgkin lymphoma, nodular sclerosis, grade 2",alternate
9670,3,"Malignant lymphoma, small B lymphocytes, NOS [OBS], see 9823/3 (ICD-O-3 update)",preferred
9670,3,"Malignant lymphoma, small lymphocytic, NOS",alternate
9670,3,"Malignant lymphoma, lymphocytic, well differentiated, diffuse",alternate
9670,3,"Malignant lymphoma, lymphocytic, NOS",alternate
9670,3,"Malignant lymphoma, lymphocytic, diffuse, NOS",alternate
9670,3,"Malignant lymphoma, small cell, NOS",alternate
9670,3,"Malignant lymphoma, small lymphocytic, diffuse",alternate
9670,3,"Malignant lymphoma, small cell diffuse",alternate
9671,3,Lymphoplasmacytic lymphoma,preferred
9671,3,"Malignant lymphoma, lymphoplasmacytoid",alternate
9671,3,Immunocytoma,alternate
9671,3,"Malignant lymphoma, plasmacytoid",alternate
9671,3,Plasmacytic lymphoma,alternate
9673,3,Mantle cell lymphoma,preferred
9673,3,Malignant lymphomatous polyposis,alternate
9673,3,Mantle zone lymphoma,alternate
9673,3,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",alternate
9673,3,"Malignant lymphoma, centrocytic",alternate
9675,3,"Malignant lymphoma, mixed small and large cell, diffuse [OBS], see 9690/3",preferred
9675,3,"Malignant lymphoma, mixed lymphocytic-histiocytic, diffuse",alternate
9675,3,"Malignant lymphoma, mixed cell type, diffuse",alternate
9675,3,"Malignant lymphoma, centroblastic- centrocytic, NOS",alternate
9675,3,"Malignant lymphoma, centroblastic- centrocytic, diffuse",alternate
9678,3,Primary effusion lymphoma,preferred
9679,3,"Primary mediastinal (thymic) large B-cell lymphoma (C37.9, C38.3)",preferred
9679,3,Thymic large B-cell lymphoma,alternate
9680,3,Diffuse large B-cell lymphoma (DLBCL),preferred
9680,3,"Diffuse large B-cell lymphoma, NOS",alternate
9680,3,"Malignant lymphoma, large cell, NOS",alternate
9680,3,"Malignant lymphoma, large B-cell, NOS",alternate
9680,3,"Malignant lymphoma, histiocytic, NOS",alternate
9680,3,"Malignant lymphoma, histiocytic, diffuse",alternate
9680,3,"Malignant lymphoma, large cell, cleaved and noncleaved",alternate
9680,3,"Malignant lymphoma, large cell, diffuse, NOS",alternate
9680,3,"Malignant lymphoma, large cleaved cell, NOS",alternate
9680,3,"Malignant lymphoma, large cell, cleaved, diffuse",alternate
9680,3,"Malignant lymphoma, large cell, cleaved, NOS",alternate
9680,3,"Malignant lymphoma, large cell, noncleaved, diffuse",alternate
9680,3,"Malignant lymphoma, large cell, noncleaved, NOS",alternate
9680,3,"Malignant lymphoma, noncleaved, diffuse, NOS",alternate
9680,3,"Malignant lymphoma, noncleaved, NOS",alternate
9680,3,"Malignant lymphoma, large B-cell, diffuse, centroblastic, NOS",alternate
9680,3,"Malignant lymphoma, centroblastic, NOS",alternate
9680,3,"Malignant lymphoma, centroblastic, diffuse",alternate
9680,3,Intravascular large B-cell lymphoma (2001-2009),alternate
9680,3,Intravascular B-cell lymphoma,alternate
9680,3,Angioendotheliomatosis (2001-2009),alternate
9680,3,Angiotropic lymphoma,alternate
9680,3,T-cell rich large B-cell lymphoma,alternate
9680,3,Histiocyte-rich large B-cell lymphoma,alternate
9680,3,T-cell rich/histiocyte-rich large B-cell lymphoma,alternate
9680,3,Anaplastic large B-cell lymphoma,alternate
9684,3,"Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS [OBS], see 9680/3 (ICD-O-3 update)",preferred
9684,3,Immunoblastic sarcoma,alternate
9684,3,"Malignant lymphoma, large cell, immunoblastic",alternate
9684,3,Plasmablastic lymphoma (2001-2009: See 9735),alternate
9684,3,"Malignant lymphoma, immunoblastic, NOS",alternate
9687,3,Burkitt lymphoma,preferred
9687,3,Burkitt tumor,alternate
9687,3,"Malignant lymphoma, undifferentiated, Burkitt type",alternate
9687,3,"Malignant lymphoma, small noncleaved, Burkitt type",alternate
9687,3,Burkitt-like lymphoma,alternate
9688,3,T-cell histiocyte-rich large B-cell lymphoma (C77._),preferred
9689,3,Splenic marginal zone lymphoma (C42.2),preferred
9689,3,"Splenic marginal zone lymphoma, NOS",alternate
9689,3,Splenic lymphoma with villous lymphocytes,alternate
9690,3,Follicular lymphoma,preferred
9690,3,"Malignant lymphoma, follicular, NOS",alternate
9690,3,"Malignant lymphoma, follicle center, follicular",alternate
9690,3,"Malignant lymphoma, follicle center, NOS",alternate
9690,3,"Malignant lymphoma, centroblastic- centrocytic, follicular",alternate
9690,3,"Malignant lymphoma, nodular, NOS",alternate
9690,3,"Malignant lymphoma, lymphocytic, nodular, NOS",alternate
9691,3,"Follicular lymphoma, grade 2",preferred
9691,3,"Malignant lymphoma, mixed lymphocytic-histiocytic, nodular",alternate
9691,3,"Malignant lymphoma, mixed cell type, follicular",alternate
9691,3,"Malignant lymphoma, mixed cell type, nodular",alternate
9691,3,"Malignant lymphoma, mixed small cleaved and large cell, follicular",alternate
9695,3,"Follicular lymphoma, grade 1",preferred
9695,3,"Malignant lymphoma, small cleaved cell, follicular",alternate
9695,3,"Follicular lymphoma, small cleaved cell",alternate
9695,3,"Malignant lymphoma, lymphocytic, poorly differentiated, nodular",alternate
9698,3,"Follicular lymphoma, grade 3",preferred
9698,3,"Malignant lymphoma, large cell, follicular, NOS",alternate
9698,3,"Malignant lymphoma, large cell, noncleaved, follicular",alternate
9698,3,"Malignant lymphoma, histiocytic, nodular",alternate
9698,3,"Malignant lymphoma, noncleaved cell, follicular, NOS",alternate
9698,3,"Malignant lymphoma, large cleaved cell, follicular",alternate
9698,3,"Malignant lymphoma, centroblastic, follicular",alternate
9698,3,"Malignant lymphoma, lymphocytic, well differentiated, nodular",alternate
9699,3,Extranodal marginal zone lymphoma of mucosal-associated lymphoid tissue (MALT lymphoma),preferred
9699,3,Bronchial-associated lymphoid tissue lymphoma,alternate
9699,3,BALT lymphoma,alternate
9699,3,Skin-associated lymphoid tissue lymphoma,alternate
9699,3,SALT lymphoma,alternate
9699,3,Monocytoid B-cell lymphoma,alternate
9699,3,Nodal marginal zone lymphoma,alternate
9699,3,"Marginal zone lymphoma, NOS",alternate
9699,3,Mucosal-associated lymphoid tissue lymphoma,alternate
9699,3,MALT lymphoma,alternate
9700,3,Mycosis fungoides (C44._),preferred
9700,3,Pagetoid reticulosis,alternate
9701,3,Sezary syndrome (C44._),preferred
9701,3,Sezary disease,alternate
9702,3,"Peripheral T-cell lymphoma, NOS",preferred
9702,3,"Peripheral T-cell lymphoma, NOS",alternate
9702,3,"T-cell lymphoma, NOS",alternate
9702,3,"Peripheral T-cell lymphoma, pleomorphic small cell",alternate
9702,3,"Peripheral T-cell lymphoma, pleomorphic medium and large cell",alternate
9702,3,"Peripheral T-cell lymphoma, large cell",alternate
9702,3,T-zone lymphoma,alternate
9702,3,Lymphoepithelioid lymphoma,alternate
9702,3,Lennert lymphoma,alternate
9705,3,Angioimmunoblastic T-cell lymphoma,preferred
9705,3,"Peripheral T-cell lymphoma, AILD (Angioimmunoblastic",alternate
9705,3,Angioimmunoblastic lymphoma,alternate
9708,3,Subcutaneous panniculitis-like T-cell lymphoma (C49._),preferred
9709,3,Primary cutaneous T-cell lymphoma (C44._),preferred
9709,3,"Cutaneous lymphoma, NOS",alternate
9712,3,Intravascular large B-cell lymphoma (ICD-O-3 update),preferred
9712,3,Angioendotheliomatosis (2010+),alternate
9714,3,"Anaplastic large cell lymphoma, ALK-positive",preferred
9714,3,Large cell (Ki-1+) lymphoma,alternate
9714,3,"Anaplastic large cell lymphoma, NOS",alternate
9714,3,"Anaplastic large cell lymphoma, CD30+",alternate
9716,3,Hepatosplenic T-cell lymphoma (C42.2),preferred
9717,3,Enteropathy-associated T-cell lymphoma,preferred
9717,3,Enteropathy type intestinal T-cell lymphoma,alternate
9717,3,Enteropathy associated T-cell lymphoma,alternate
9718,1,Lymphomatoid papulosis,preferred
9718,3,Primary cutaneous CD30-positive T-cell lymphoproliferative disorders (C44._),preferred
9718,3,Lymphomatoid papulosis,alternate
9718,3,Primary cutaneous anaplastic large cell lymphoma,alternate
9718,3,Primary cutaneous CD30+ large T-cell lymphoma,alternate
9719,3,"Extranodal NK--/T-cell lymphoma, nasal type (ICD-O-3 update)",preferred
9719,3,T/NK-cell lymphoma,alternate
9719,3,Angiocentric T-cell lymphoma,alternate
9719,3,"Malignant reticulosis, NOS",alternate
9719,3,Malignant midline reticulosis,alternate
9719,3,Polymorphic reticulosis,alternate
9724,3,Systemic EBV-positive T-cell lymphoproliferative disease of childhood (ICD-O-3 update),preferred
9725,3,Hydroa vacciniforme-like lymphoma (ICD-O-3 update) (C44.._),preferred
9726,3,"Primary cutaneous gamma delta T-cell lymphoma (ICD-O-3 update) (C44._, C49._)",preferred
9727,3,Blastic plasmacytoid dendritic cell neoplasm,preferred
9727,3,"Malignant lymphoma, lymphoblastic, NOS",alternate
9727,3,"Malignant lymphoma, convoluted cell",alternate
9727,3,Lymphoblastoma,alternate
9728,3,"Precursor B-lymphoblastic lymphoma [OBS], see 9811/3 (ICD-O-3 update)",preferred
9729,3,"Precursor T--cell lymphoblastic lymphoma, NOS [OBS], see 9837/3 (ICD-O-3 update)",preferred
9731,3,"Solitary plasmacytoma of bone (C40._, C41._)",preferred
9731,3,Plasmacytoma of bone,alternate
9731,3,Plasma cell tumor,alternate
9731,3,Solitary myeloma,alternate
9731,3,Solitary plasmacytoma,alternate
9732,3,Plasma cell myeloma (C42.1),preferred
9732,3,"Myeloma, NOS",alternate
9732,3,Myelomatosis,alternate
9732,3,Plasma cell myeloma,alternate
9732,3,Multiple myeloma,alternate
9733,3,"Plasma cell leukemia [OBS], see 9732/3 (ICD-O-3 update) (C42.1)",preferred
9733,3,Plasmacytic leukemia,alternate
9734,3,Extraosseous plasmacytoma,preferred
9735,3,Plasmablastic lymphoma (ICD-O-3 update),preferred
9737,3,ALK-positive large B-cell lymphoma,preferred
9738,3,Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease (ICD-O-3 update),preferred
9740,1,Solitary mastocytoma of skin,preferred
9740,1,"Mast cell tumor, NOS",alternate
9740,3,Mast cell sarcoma,preferred
9740,3,Malignant mast cell tumor,alternate
9740,3,Malignant mastocytoma,alternate
9741,1,Indolent systemic mastocytosis,preferred
9741,3,Systemic mastocytosis (C42.1),preferred
9741,3,Systemic tissue mast cell disease,alternate
9742,3,Mast cell leukemia (C42.1),preferred
9750,3,"Malignant histiocytosis [OBS], see code 9751/3 (ICD-O-3 update)",preferred
9750,3,Histiocytic medullary reticulosis,alternate
9751,1,"Langerhans cell histiocytosis, NOS",preferred
9751,1,Langerhans cell granulomatosis,alternate
9751,1,"Histiocytosis X, NOS",alternate
9751,3,Langerhans cell histiocytosis (ICD-O-3 update),preferred
9752,1,"Langerhans cell histiocytosis, unifocal [OBS], see code 9751/3 (ICD-O-3 update)",preferred
9752,1,"Langerhans cell granulomatosis, unifocal",alternate
9752,1,"Langerhans cell histiocytosis, mono-ostotic",alternate
9752,1,Eosinophilic granuloma,alternate
9753,1,"Langerhans cell histiocytosis, multifocal [OBS], see code 9751/3 (ICD-O-3 update)",preferred
9753,1,"Langerhans cell histiocytosis, poly-ostotic",alternate
9753,1,Hand-Schuller-Christian disease,alternate
9754,3,"Langerhans cell histiocytosis, disseminated [OBS], see code 9751/3 (ICD-O-3 update)",preferred
9754,3,"Langerhans cell histiocytosis, generalized",alternate
9754,3,Letterer-Siwe disease,alternate
9754,3,Acute progressive histiocytosis X,alternate
9754,3,Nonlipid reticuloendotheliosis,alternate
9755,3,Histiocytic sarcoma,preferred
9755,3,True histiocytic lymphoma,alternate
9756,3,Langerhans cell sarcoma,preferred
9757,3,Interdigitating dendritic cell sarcoma,preferred
9757,3,Interdigitating cell sarcoma,alternate
9757,3,"Dendritic cell sarcoma, NOS",alternate
9758,3,Follicular dendritic cell sarcoma,preferred
9758,3,Follicular dendritic cell tumor,alternate
9759,3,Fibroblastic reticular cell tumor (ICD-O-3 update),preferred
9760,3,"Immunoproliferative disease, NOS [OBS] (ICD-O-3 update)",preferred
9761,3,Waldenstrom macroglobulinemia (C42.0),preferred
9762,3,Heavy chain disease,preferred
9762,3,Mu heavy chain disease,alternate
9762,3,Gamma heavy chain disease,alternate
9762,3,Franklin disease,alternate
9762,3,Alpha heavy chain disease,alternate
9764,3,"Immunoproliferative small intestinal disease [OBS], see code 9762/3 (ICD-O-3 update)",preferred
9764,3,Mediterranean lymphoma,alternate
9765,1,Monoclonal gammopathy of undetermined significance,preferred
9765,1,MGUS,alternate
9765,1,"Monoclonal gammopathy, NOS",alternate
9766,1,Angiocentric immunoproliferative lesion,preferred
9766,1,Lymphoid granulomatosis,alternate
9766,3,"Angiocentric immunoproliferative lesion, malignant",preferred
9767,1,Angioimmunoblastic lymphadenopathy,preferred
9767,1,Immunoblastic lymphadenopathy (IBL) [obs],alternate
9768,1,T gamma-lymphoproliferative disease,preferred
9769,1,Immunoglobulin deposition disease,preferred
9769,1,Systemic light chain disease,alternate
9769,1,Primary amyloidosis,alternate
9769,3,"Immunoglobulin deposition disease, malignant",preferred
9800,3,"Leukemia, NOS (C42.1)",preferred
9800,3,"Subacute leukemia, NOS",alternate
9800,3,"Chronic leukemia, NOS",alternate
9800,3,"Aleukemic leukemia, NOS",alternate
9801,3,Acute undifferentiated leukemia (C42.1),preferred
9801,3,Blast cell leukemia,alternate
9801,3,Undifferentiated leukemia,alternate
9801,3,Stem cell leukemia,alternate
9805,3,"Acute biphenotypic leukemia [OBS], See codes 9806/3-9809/3 (ICD-O-3 update) (C42.1)",preferred
9805,3,Acute mixed lineage leukemia,alternate
9805,3,Acute bilineal leukemia,alternate
9806,3,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR-ABL1 (ICD-O-3 update) (C42.1),preferred
9807,3,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged (ICD-O-3 update) (C42.1),preferred
9808,3,"Mixed phenotype acute leukemia, B/myeloid, NOS (ICD-O-3 update) (C42.1)",preferred
9809,3,"Mixed phenotype acute leukemia, T/myeloid, NOS (ICD-O-3 update) (C42.1)",preferred
9811,3,"B lymphoblastic leukemia/lymphoma, NOS (ICD-O-3 update)",preferred
9812,3,B Lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 (ICD-O-3 update),preferred
9813,3,B Lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged (ICD-O-3 update),preferred
9814,3,B Lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (ICD-O-3 update),preferred
9815,3,B Lymphoblastic leukemia/lymphoma with hyperdiploidy (ICD-O-3 update),preferred
9816,3,B Lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL) (ICD-O-3 update),preferred
9817,3,B Lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH (ICD-O-3 update),preferred
9818,3,B Lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);E2A-PBX1 (TCF3-PBX1) (ICD-O-3 update),preferred
9820,3,"Lymphoid leukemia, NOS (C42.1)",preferred
9820,3,"Lymphocytic leukemia, NOS",alternate
9820,3,"Lymphatic leukemia, NOS",alternate
9820,3,Subacute lymphoid leukemia,alternate
9820,3,Subacute lymphocytic leukemia,alternate
9820,3,Subacute lymphatic leukemia,alternate
9820,3,Aleukemic lymphoid leukemia,alternate
9820,3,Aleukemic lymphocytic leukemia,alternate
9820,3,Aleukemic lymphatic leukemia,alternate
9820,3,Lymphosarcoma cell leukemia,alternate
9823,3,Chronic lymphocytic leukemia/small lymphocytic lymphoma (ICD-O-3 update),preferred
9823,3,"Chronic lymphocytic leukemia, B-cell type",alternate
9823,3,Chronic lymphocytic leukemia,alternate
9823,3,Chronic lymphoid leukemia,alternate
9823,3,Chronic lymphatic leukemia,alternate
9826,3,Burkitt cell leukemia (C42.1),preferred
9826,3,B-ALL,alternate
9826,3,FAB L3,alternate
9826,3,"Acute lymphoblastic leukemia, mature B-cell type",alternate
9826,3,"Acute leukemia, Burkitt type",alternate
9827,3,Adult T-cell leukemia/lymphoma (ICD-O-3 update),preferred
9827,3,Adult T-cell lymphoma/leukemia,alternate
9827,3,Adult T-cell lymphoma,alternate
9827,3,Adult T-cell leukemia,alternate
9831,1,"T-cell large granular lymphocytic leukemia, low malignant potential (C42.1)",preferred
9831,1,T-cell large granular lymphocytosis,alternate
9831,1,NK-cell large granular lymphocytic leukemia,alternate
9831,1,"Large granular lymphocytosis, NOS",alternate
9831,3,T-cell large granular lymphocytic leukemia,preferred
9832,3,"Prolymphocytic leukemia, NOS (C42.1)",preferred
9833,3,B-cell prolymphocytic leukemia (ICD-O-3 update) (C42.1),preferred
9834,3,T-cell prolymphocytic leukemia (ICD-O-3 update) (C42.1),preferred
9835,3,"Precursor cell lymphoblastic leukemia, NOS [OBS} see 9811/3 (ICD-O-3 update) (C42.1)",preferred
9835,3,"Lymphoblastic leukemia, NOS",alternate
9835,3,FAB L1,alternate
9835,3,"Acute lymphoblastic leukemia, L2 type, NOS",alternate
9835,3,FAB L2,alternate
9835,3,"Precursor cell lymphoblastic leukemia, not phenotyped",alternate
9835,3,"Acute lymphoblastic leukemia, NOS",alternate
9835,3,"Acute lymphoblastic leukemia, precursor-cell type",alternate
9835,3,"Acute lymphoblastic leukemia-lymphoma, NOS",alternate
9835,3,Acute lymphocytic leukemia,alternate
9835,3,Acute lymphoid leukemia,alternate
9835,3,Acute lymphatic leukemia,alternate
9836,3,Precursor B-cell lymphoblastic leukemia [OBS} see code 9811/3 (ICD-O-3 update) (C42.1),preferred
9836,3,Pro-B ALL,alternate
9836,3,Common precursor B ALL,alternate
9836,3,Pre-B ALL,alternate
9836,3,Pre-pre-B ALL,alternate
9836,3,Common ALL,alternate
9836,3,c-ALL,alternate
9837,3,T lymphoblastic leukemia/lymphoma (ICD-O-3 update),preferred
9837,3,Pro-T ALL,alternate
9837,3,Pre-T ALL,alternate
9837,3,Cortical T ALL,alternate
9837,3,Mature T ALL,alternate
9840,3,Acute erythroid leukemia (C42.1),preferred
9840,3,M6B,alternate
9840,3,Erythroleukemia,alternate
9840,3,FAB M6,alternate
9840,3,AML M6,alternate
9840,3,"Erythremic myelosis, NOS",alternate
9840,3,Acute erythremia,alternate
9840,3,Di Guglielmo disease,alternate
9840,3,Acute erythremic myelosis,alternate
9840,3,Acute erythroid leukemia,alternate
9840,3,M6A,alternate
9860,3,"Myeloid leukemia, NOS (C42.1)",preferred
9860,3,"Non-lymphocytic leukemia, NOS",alternate
9860,3,"Granulocytic leukemia, NOS",alternate
9860,3,"Myelogenous leukemia, NOS",alternate
9860,3,"Myelomonocytic leukemia, NOS",alternate
9860,3,"Myelocytic leukemia, NOS",alternate
9860,3,Subacute myeloid leukemia,alternate
9860,3,Subacute granulocytic leukemia,alternate
9860,3,Subacute myelogenous leukemia,alternate
9860,3,Aleukemic myeloid leukemia,alternate
9860,3,Aleukemic granulocytic leukemia,alternate
9860,3,Aleukemic myelogenous leukemia,alternate
9860,3,Eosinophilic leukemia,alternate
9860,3,"Monocytic leukemia, NOS",alternate
9860,3,Subacute monocytic leukemia,alternate
9860,3,Chronic monocytic leukemia,alternate
9860,3,Aleukemic monocytic leukemia,alternate
9861,3,"Acute myeloid leukemia, NOS (C42.1)",preferred
9861,3,Acute non-lymphocytic leukemia,alternate
9861,3,Acute granulocytic leukemia,alternate
9861,3,Acute myelogenous leukemia,alternate
9861,3,Acute myelocytic leukemia,alternate
9863,3,"Chronic myeloid leukemia, NOS (C42.1)",preferred
9863,3,"Chronic granulocytic leukemia, NOS",alternate
9863,3,"Chronic myelogenous leukemia, NOS",alternate
9863,3,"Chronic myelocytic leukemia, NOS",alternate
9865,3,Acute myeloid leukemia with t(6;9)(p23;q34);DEK-NUP214 (ICD-O-3 update) (C42.1),preferred
9866,3,Acute promyelocytic leukemia (AML with t(15;17)(q22;q12)) PML/RARA (C42.1),preferred
9866,3,"Acute myeloid leukemia, t(15:17)(q22",alternate
9866,3,"Acute myeloid leukemia, PML/RAR-alpha",alternate
9866,3,"Acute promyelocytic leukemia, NOS",alternate
9866,3,FAB M3,alternate
9866,3,"Acute promyelocytic leukemia, PML/RAR- alpha",alternate
9867,3,Acute myelomonocytic leukemia (C42.1),preferred
9867,3,FAB M4,alternate
9869,3,Acute myeloid leukemia with inv(3)(q21;q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 (C42.1),preferred
9870,3,Acute basophilic leukemia (C42.1),preferred
9871,3,"Acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22), CBFB-MYH11 (C42.1)",preferred
9871,3,"Acute myeloid leukemia, inv(16)(p13;q22)",alternate
9871,3,"Acute myeloid leukemia, t(16;16)(p13;q11)",alternate
9871,3,"Acute myeloid leukemia, CBF-beta/MYH11",alternate
9871,3,Acute myelomonocytic leukemia with abnormal eosinophils,alternate
9871,3,FAB M4Eo,alternate
9872,3,Acute myeloid leukemia with minimal differentiation (C42.1),preferred
9872,3,Acute myeloblastic leukemia,alternate
9872,3,FAB M0,alternate
9873,3,Acute myeloid leukemia without maturation (C42.1),preferred
9873,3,FAB M1,alternate
9874,3,Acute myeloblastic leukemia with maturation (C42.1),preferred
9874,3,"FAB M2, NOS",alternate
9875,3,"Chronic myelogenous leukemia, BCR/ABL1 positive (C42.1)",preferred
9875,3,"Chronic granulocytic leukemia, Philadelphia chromosome (Ph1) positive",alternate
9875,3,"Chronic granulocytic leukemia, t(9",alternate
9875,3,"Chronic granulocytic leukemia, BCR/ABL",alternate
9875,3,"Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive",alternate
9875,3,"Chronic myelogenous leukemia, t(9",alternate
9876,3,"Atypical chronic myeloid leukemia, BCR-ABL1 negative (C42.1)",preferred
9876,3,"Atypical chronic myeloid leukemia, Philadelphia chromosome (Ph1) negative",alternate
9891,3,Acute monoblastic and monocytic leukemia,preferred
9891,3,Acute monoblastic leukemia,alternate
9891,3,"Monoblastic leukemia, NOS",alternate
9891,3,FAB M5,alternate
9895,3,Acute myeloid leukemia with myelodysplasia-related changes (ICD-O-3 update) (C42.1),preferred
9895,3,Acute myeloid leukemia with prior myelodysplastic syndrome,alternate
9895,3,Acute myeloid leukemia without prior myelodysplastic syndrome,alternate
9896,3,"Acute myeloid leukemia, t(8;21)(q22;q22) RUNX1-RUNX1T1 (ICD-O-3 update) (C42.1)",preferred
9896,3,"Acute myeloid leukemia, AML1(CBF- alpha)/ETO",alternate
9896,3,"FAB M2, t(8",alternate
9896,3,"FAB M2, AML1(CBF-alpha)/ETO",alternate
9897,3,Acute myeloid leukemia with t(9;11)(p22;q23);MLLT3-MLL (ICD-O-3 update) (C42.1),preferred
9897,3,"Acute myeloid leukemia, MLL",alternate
9898,1,Transient abnormal myelopoiesis (ICD-O-3 update (C42.1),preferred
9898,3,Myeloid leukemia with Down Syndrome (ICD-O-3 update) (C42.1),preferred
9910,3,Acute megakaryoblastic leukemia (C42.1),preferred
9910,3,Megakaryocytic leukemia,alternate
9910,3,FAB M7,alternate
9911,3,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 (ICD-O-3 update) (C42.1),preferred
9920,3,Therapy-related myeloid neoplasm (ICD-O-3 update) (C42.1),preferred
9920,3,"Therapy-related acute myeloid leukemia, epipodophyllotoxin-related",alternate
9920,3,"Therapy-related acute myeloid leukemia, alkylating agent related",alternate
9930,3,Myeloid sarcoma,preferred
9930,3,Granulocytic sarcoma,alternate
9930,3,Chloroma,alternate
9931,3,Acute panmyelosis with myelofibrosis (C42.1),preferred
9931,3,"Acute panmyelosis, NOS",alternate
9931,3,Acute myelofibrosis,alternate
9931,3,"Acute myelosclerosis, NOS",alternate
9931,3,Malignant myelosclerosis,alternate
9940,3,Hairy cell leukemia (C42.1),preferred
9940,3,Leukemic reticuloendotheliosis,alternate
9945,3,Chronic myelomonocytic leukemia (C42.1),preferred
9945,3,"Chronic myelomonocytic leukemia, Type I",alternate
9945,3,"Chronic myelomonocytic leukemia, Type II",alternate
9945,3,Chronic myelomonocytic leukemia in transformation,alternate
9946,3,Juvenile myelomonocytic leukemia (C42.1),preferred
9946,3,Juvenile chronic myelomonocytic leukemia,alternate
9948,3,Aggressive NK-cell leukemia (C42.1),preferred
9950,3,Polycythemia vera (C42.1),preferred
9950,3,Polycythemia rubra vera,alternate
9950,3,Proliferative polycythemia,alternate
9950,3,Chronic erythremia,alternate
9960,3,"Chronic myeloproliferative disease, NOS [OBS], see 9975/3 (ICD-O-3 update) (C42.1)",preferred
9960,3,Chronic myeloproliferative disorder,alternate
9961,3,Primary myelofibrosis (C42.1),preferred
9961,3,Myelofibrosis as a result of myeloproliferative disease,alternate
9961,3,Chronic idiopathic myelofibrosis,alternate
9961,3,Agnogenic myeloid metaplasia,alternate
9961,3,Megakaryocytic myelosclerosis,alternate
9961,3,Myelofibrosis with myeloid metaplasia,alternate
9962,3,Essential thrombocythemia (C42.1),preferred
9962,3,Idiopathic thrombocythemia,alternate
9962,3,Essential hemorrhagic thrombocythemia,alternate
9962,3,Idiopathic hemorrhagic thrombocythemia,alternate
9963,3,Chronic neutrophilic leukemia (C42.1),preferred
9964,3,"Chronic eosinophilic leukemia, NOS (C42.1)",preferred
9964,3,Chronic eosinophilic leukemia,alternate
9965,3,Myeloid and lymphoid neoplasms with PDGFRA rearrangement (ICD-O-3 update) (C42.1),preferred
9966,3,Myeloid neoplasms with PDGFRB rearrangement (ICD-O-3 update) (C42.1),preferred
9967,3,Myeloid and lymphoid neoplasms with FGFR1 ICD-O-3 update) (C42.1),preferred
9970,1,"Lymphoproliferative disorder, NOS",preferred
9970,1,"Lymphoproliferative disease, NOS",alternate
9970,3,"Lymphoproliferative disease, malignant, NOS",preferred
9971,1,Plasmacytic hyperplasia (ICD-O-3 update),preferred
9971,3,Post transplant lymphoproliferative disorder (ICD-O-3 update),preferred
9975,1,"Myeloproliferative disease, NOS",preferred
9975,3,Myelodsyplastic/myeloproliferative neoplasm unclassifiable (ICD-O-3 update) (C42.1),preferred
9980,3,Myelodysplastic syndrome with single lineage dysplasia,preferred
9980,3,Refractory anemia without sideroblasts,alternate
9982,3,Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia,preferred
9982,3,Refractory anemia with ringed sideroblasts,alternate
9982,3,RARS,alternate
9983,3,Refractory anemia with excess blasts (C42.1),preferred
9983,3,RAEB II,alternate
9983,3,RAEB,alternate
9983,3,RAEB I,alternate
9984,3,"Refractory anemia with excess blasts in transformation [OBS], see 9983/3 (ICD-O-3 update) (C42.1)",preferred
9984,3,RAEB-T,alternate
9985,3,Refractory cytopenia with multilineage dysplasia (C42.1),preferred
9986,3,Myelodysplastic syndrome associated with isolated del(5q) (C42.1),preferred
9987,3,"Therapy related myelodysplastic syndrome, NOS [OBS], see 9920/3 (ICD-O-3 update)",preferred
9987,3,"Therapy-related myelodysplastic syndrome, alkylating agent related",alternate
9987,3,"Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related",alternate
9989,3,"Myelodysplastic syndrome, unclassifiable (ICD-O-3 update) (C42.1)",preferred
9989,3,Preleukemia,alternate
9989,3,Preleukemic syndrome,alternate
9991,3,Refractory neutropenia (ICD-O-3 update) (C42.1),preferred
9992,3,Refractory thrombocytopenia (ICD-O-3 Update) (C42.1),preferred
